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Hydrogels consisting of aqueous 3D crosslinked polymer network are very similar to living tissue 
properties such as elasticity, biocompatibility, hydrophilicity and porosity, and are widely used in 
various biomedical applications. They are widely used as promising materials for therapeutic delivery, 
contact lenses, bone cements, wound dressings, and 3D tissue scaffolds for tissue engineering and so 
on. However, to control their properties independently to suit biomedical application purpose is often 
challenge. 
 One of challenge is interdependency of hydrogel properties, since controlling the crosslinking 
density can also affects their other properties such as the degradation rate, hydrophilicity and 
mechanical properties. Also, their fabrication mechanisms are often an issue. Free radical 
polymerization, most commonly used to form hydrogels, is usually initiated by free radical-generating 
compounds, radiation or heating, which activation and residual initiators often damage cells and 
tissues. In addition, it is difficult to control the crosslinking kinetics at low toxicity levels. Therefore, 
an “in situ” crosslinking reaction would be highly favored for hydrogel fabrication in biomedical 
application. because, they react under mild conditions without using initiator and their crosslinking 
kinetics can be widely controlled with low toxicity.  
Due to many things in addition to the aforementioned challenges, it is important to control these 
properties at different levels to meet the specific requirements. Therefore, in this study, in order to 
overcome limitations while maintaining their intrinsic properties, a multifunctional polymer-based 
hydrogel was developed, and various properties were controlled. It is expected to exhibit superior 
properties to increase the potential use in the biomedical industry. 
 In chapter 2, the protein release rates from hydrogels were controlled by varying the physical 
properties of the hydrogels while maintaining their crosslinking density. In general, the degree of 
crosslinking is adjusted to control the protein release of the hydrogel as a carrier. However, it is not 
preferred because the crosslinking density affects the mechanical properties of the hydrogels, in which 
the mechanical and diffusional properties are inversely correlated. To overcome these issues, by 
presenting functional groups having positive charge, negative charge, and hydrophobicity, 
respectively, on the poly(ethylene glycol) (PEG) chains, the release of proteins having various 
isoelectric points was controlled through electrostatic interactions.  
In the chapter 3, the mechanical properties and degradation behavior of PEG diacrylate (PEGDA)-
polyethyleneimine (PEI) hydrogels prepared by in situ crosslinking between PEGDA and PEI via 
Michael addition were explored. Generally, cross-linked hydrogels involving the use of initiators to 
start the process often exhibit cytotoxicity depending on reagent concentrations. Therefore, their 
dosage must be applied carefully to prevent cytotoxicity while maintaining the ability to initiate a 
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crosslinking reaction. As the alternative to these issues, PEGDA and PEI were used to fabricate 
hydrogels through "in situ" crosslinking reactions that occur under mild conditions and do not involve 
the use of initiators. We also explored the drug release kinetics of PEGDA-PEI hydrogels depending 
on their physical properties and degradation behavior. 
 In the chapter 4, the mechanical properties of in situ forming chitosan hydrogels via Schiff base 
formation were controlled by introducing tunable polymer graft architecture. Due to the mechanical 
properties of in situ forming hydrogels depend on the crosslinking density which also controls the 
gelation rate, it is a significant challenge to independently control the mechanics and gelation kinetics. 
We synthesized PEG with varying lengths and densities conjugated to the chitosan backbone, which 
not only allowed dissolution in neutral aqueous solutions but also the control of mechanical properties 
of hydrogel while maintaining facile gelation kinetics. In addition, the tissue adhesive properties of 
resulting hydrogels were evaluated by ex vivo and in vivo models, demonstrating their clinical 
potential. 
In the last chapter, polyaspartamide presenting amine groups with controllable grafting density and 
length was synthesized using diamines with varying length of poly(ethylene glycol) linker. Small 
molecules can only have a few functional groups and often-show limited solubility in various solvents, 
limiting their controllable range. On the other hand, polymers that have functional groups throughout 
their repeating units serving as sites for chemical reactions can present more reactive functional groups 
than small molecules, resulting considered highly effective crosslinkers to develop materials with 
variable mechanical properties. We demonstrated the potential application as an injectable drug 
delivery systems undergo facile degradation and complete dissolution in physiological conditions, 
regardless of mechanical properties, by adjusting the graft architecture of poly(2-hydroxyethyl 






































ABSTRACT ....................................................................................................................................... I 
CONTENTS.....................................................................................................................................IV 
LIST OF FIGURES AND TABLES ............................................................................................ VII 
CHAPTER 1. Introduction ................................................................................................................ 1 
1.1 Research Background ................................................................................................................. 1 
1.2 Research Purpose and Motivation ............................................................................................. 2 
CHAPTER 2. Modulation of functional pendant chains within poly(ethylene glycol) hydrogels 
for refined control of protein release ................................................................................................ 3 
2.1 Introduction ................................................................................................................................. 3 
2.2 Materials and Methods ............................................................................................................... 4 
2.2.1 Synthesis of Poly(ethylene glycol) dimethacrylate (PEGDA) ................................................ 4 
2.2.2 Synthesis of heterobifunctional poly(ethylene glycol) monomethacrylate (PEGMA) .......... 4 
2.2.3 Fabrication of hydrogels ........................................................................................................ 8 
2.2.4 Evaluation of mechanical properties of hydrogels ................................................................ 8 
2.2.5 Evaluation of protein release from hydrogels ........................................................................ 8 
2.3 Results and Discussion ................................................................................................................ 9 
2.3.1 Synthesis of heterobifunctional PEGMA ................................................................................ 9 
2.3.2 Mechanical properties of PEG hydrogel with functional pendant chains ........................... 11 
2.3.3 Protein release from PEG hydrogel with functional pendant chains .................................. 14 
2.4 Conclusion ................................................................................................................................. 23 
CHAPTER 3. Integrative control of mechanical and degradation properties of in situ 
crosslinkable polyamine-based hydrogels for dual-mode drug release kinetics ......................... 25 
3.1 Introduction ............................................................................................................................... 25 
3.2 Materials and Methods ............................................................................................................. 26 
3.2.1 Synthesis of poly(ethylene glycol) diacrylate (PEGDA) ...................................................... 26 
3.2.2 PEGDA-PEI hydrogel fabrication ....................................................................................... 27 
3.2.3 Mechanical properties and degradation of PEGDA-PEI hydrogels ................................... 27 
3.2.4 Drug release profiles from PEGDA-PEI hydrogels ............................................................. 28 
3.3 Results and Discussion .............................................................................................................. 29 
3.3.1 Mechanical properties of PEGDA-PEI hydrogels ............................................................... 29 
3.3.2 Gelation kinetics .................................................................................................................. 30 
3.3.3 Rigidity ................................................................................................................................. 33 
V 
 
3.3.4 Degradation of PEGDA-PEI hydrogels ............................................................................... 36 
3.3.5 Degradation of PEGDA-PEI hydrogels ............................................................................... 39 
3.4 Conclusion ................................................................................................................................. 43 
CHAPTER 4. In situ facile-forming chitosan hydrogels with tunable physicomechanical and 
tissue adhesive properties by polymer graft architecture ............................................................. 44 
4.1 Introduction ............................................................................................................................... 44 
4.2 Materials and Methods ............................................................................................................. 46 
4.2.1 Synthesis of PEG-grafted chitosan (‘PEG-g-Cs’) and PEG-dialdehyde ............................. 46 
4.2.2 Fabrication of Cs-PEG hydrogels ....................................................................................... 48 
4.2.3 Mechanical and rheological properties of Cs-PEG hydrogels ............................................ 48 
4.2.4 Diffusional properties of Cs-PEG hydrogels ....................................................................... 49 
4.2.5 Tissue adhesive properties of Cs-PEG hydrogels ................................................................ 49 
4.2.6 Anti-microbial properties of PEG-g-Cs ............................................................................... 51 
4.2.7 Swept-Source Optical Coherence Tomography (SS-OCT) .................................................. 51 
4.3 Results and Discussion .............................................................................................................. 52 
4.3.1 Synthesis and physical properties of PEG-g-Cs .................................................................. 52 
4.3.2 Mechanical properties of Cs-PEG hydrogels ...................................................................... 56 
4.3.3 Diffusional properties of Cs-PEG hydrogels ....................................................................... 60 
4.3.4 Anti-microbial properties of Cs-PEG hydrogels.................................................................. 62 
4.3.5 Gelation kinetics of Cs-PEG hydrogels ............................................................................... 63 
4.3.6 Tissue adhesive properties of Cs-PEG hydrogels ................................................................ 64 
4.3.7 In vivo evaluation of Cs-PEG hydrogel as tissue sealant .................................................... 66 
4.4 Conclusion ................................................................................................................................. 70 
CHAPTER 5. In situ facile-forming chitosan hydrogels with tunable physicomechanical and 
tissue adhesive properties by polymer graft architecture ............................................................. 71 
5.1 Introduction ............................................................................................................................... 71 
5.2 Materials and Methods ............................................................................................................. 72 
5.2.1 Synthesis of Polysuccinimide (PSI) ...................................................................................... 72 
5.2.2 Synthesis of PEG-Diamine ................................................................................................... 72 
5.2.3 Synthesis of Poly(2-hydroxyethyl aspartamide)-g-Amino-Poly(ethylene glycol) (PHEA–
PEGAm) ........................................................................................................................................ 74 
5.2.4 Trinitrobenzene sulfonic acid (TNBS) assay ........................................................................ 75 
5.2.5 Synthesis of oxidized alginate .............................................................................................. 75 
5.2.6 Fabrication of PHEA–PEGAm Hydrogels .......................................................................... 75 
VI 
 
5.2.7 Mechanical and Degradation Properties of Hydrogels ....................................................... 75 
5.2.8 Drug Release Kinetics .......................................................................................................... 76 
5.2.9 Rheological Properties of Hydrogels ................................................................................... 76 
5.2.10 In Vitro Cytotoxicity ........................................................................................................... 76 
5.2.11 Ex Vivo Evaluation of Degradation Behavior of Hydrogel ............................................... 77 
5.3 Results and Discussion .............................................................................................................. 77 
5.3.1 Synthesis and Characterization of Amine-Presenting Polyaspartamide with 
Tunable Graft  Architecture ......................................................................................................... 77 
5.3.2 Fabrication and Mechanical Properties of PHEA-Linked Hydrogels ................................. 81 
5.3.3 Degradation of PHEA-Linked Hydrogels ............................................................................ 84 
5.3.4 Drug Release Kinetics of PHEA-Linked Hydrogels ............................................................. 86 
5.3.5 Ex Vivo Alg-PHEA Hydrogel Injection and Degradation ................................................... 88 
5.3.6 Dual Ionic Cross-Linked Alg-PHEA Hydrogels .................................................................. 89 
5.4 Conclusion ................................................................................................................................. 91 
CHAPTER 6. Summary and Future Perspective .......................................................................... 92 





LIST OF FIGURES AND TABLES 
 
Figure 2-1. The molecular weight distributions of (a) Sulfo-PEG, (b) TMAC-PEG, and (c) Ph-PEG, 
determined from MALDI-TOF mass spectrometry. ............................................................................. 5 
Figure 2-2. 1H-NMR spectra of (a) Sulfo-PEG, (b) TMAC-PEG, and (c) Ph-PEG. ............................ 6 
Figure 2-3. 13C-NMR spectra of (a) Sulfo-PEG, (b) TMAC-PEG, and (c) Ph-PEG. ........................... 7 
Figure 2-4. Zeta potential values of (a) proteins (albumin, insulin, and trypsin) and (b) SulfoPEGMA 
and TMAC-PEGMA, measured at 0.1 % (w/v) in 10 mM NaCl. ........................................................ 8 
Figure 2-5. (a) Fabrication of PEG hydrogels with functional pendant chains via radical 
copolymerization of PEGDA with heterobifunctional PEGMA. (b) Synthesis of heterobifunctional 
PEGMA via anionic polymerization of epoxide with an initiator containing the desired functional 
group, followed by the conjugation of methacrylate. The functional groups used in this study were 
sulfonate (negative charge), trimethylammonium chloride (positive charge) and phenyl 
(hydrophobicity) groups. .................................................................................................................... 10 
Figure 2-6. (a) The fraction of functional pendant chains (Φ) was varied while keeping the total 
number of pendant chains constant. Normalized elastic moduli (E/E0) of PEG hydrogels with varying 
Φ, measured (b,c,d) right after fabrication and (e,f,g) after incubation in PBS for 24 hours. The moduli 
were normalized with that at Φ = 0 (E0). (b,e) 10% PEGDA and 2% PEGMA, (c,f) 8% PEGDA and 
4% PEGMA, (d,g) 6% PEGDA and 6% PEGMA. ............................................................................. 11 
Figure 2-7. Elastic moduli (E) of Sulfo-PEG, TMAC-PEG, and Ph-PEG hydrogels measured right 
after fabrication (‘initial moduli’). The PEGDA and PEGMA concentrations of the hydrogels were (a) 
10% and 2%, (b) 8% and 4%, and (c) 6% and 6%. ............................................................................ 12 
Figure 2-8. (a-c) Elastic moduli (E) and (d-e) swelling ratios (Q) of Sulfo-PEG, TMAC-PEG, and Ph-
PEG hydrogels. The PEGDA and PEGMA concentrations of the hydrogels were (a,d) 10% and 2%, 
(b,e) 8% and 4%, and (c,f) 6% and 6%. E and Q were measured after 1 day of incubation in PBS. . 13 
Figure 2-9. Scanning electron microscopic (SEM) images of non-functional mPEG hydrogel, Sulfo-
PEG hydrogel, TMAC-PEG hydrogel, and Ph-PEG hydrogel at Φ = 1 (scale bar: 5 μm). (a) 10% 
PEGDA and 2% PEGMA, (b) 8% PEGDA and 4% PEGMA. ........................................................... 13 
VIII 
 
Figure 2-10. Normalized swelling ratios (Q/Q0) of PEG hydrogels with varying Φ. The swelling ratios 
were normalized with that at Φ = 0 (Q0). (a) 10% PEGDA and 2% PEGMA, (b) 8% PEGDA and 4% 
PEGMA, (c) 6% PEGDA and 6% PEGMA. ...................................................................................... 14 
Figure 2-11. (a) Protein with pI lower than 7.4 becomes negatively charged, and thus expected to have 
a greater release rate in Sulfo-PEG hydrogels via repulsion than TMAC-PEG hydrogels. The release 
profiles of albumin from (b) Sulfo-PEG hydrogels, (c) TMAC-PEG hydrogels and (d) Ph-PEG 
hydrogels. (e) The kinetic rate constants (k) and (f) exponents (n) were obtained by fitting the curves 
with Eq. 2-1. (g) Diffusion coefficients (D) were obtained by fitting the curves with Eq. 2-2. The 
PEGDA and PEGMA concentrations of the hydrogels were 8% and 4%, respectively. (*p < 0.05). . 16 
Figure 2-12. (a,b) Kinetic rate constants (k) and (c,d) diffusion coefficients (D) of albumin release 
from Sulfo-PEG, TMAC-PEG and Ph-PEG hydrogels, obtained by fitting the release profiles with Eq. 
(1) and Eq. 2-2, respectively. (*p < 0.05) (a,c) 10% PEGDA and 2% PEGMA, (b,d) 6% PEGDA and 
6% PEGMA. ....................................................................................................................................... 18 
Figure 2-13. The release profiles of insulin from (a) Sulfo-PEG hydrogels, (b) TMAC-PEG hydrogels 
and (c) Ph-PEG hydrogels. (d) The kinetic rate constants (k) and (e) exponents (n) obtained by fitting 
the curves with Eq. 2-1. (f) Diffusion coefficients (D) were obtained by fitting the curves with Eq. 2-
2. (*p < 0.05) The PEGDA and PEGMA concentrations of the hydrogels were 8% and 4%, respectively.
 ............................................................................................................................................................ 19 
Figure 2-14. (a,b) Kinetic rate constants (k) and (c,d) diffusion coefficients (D) of insulin release from 
Sulfo-PEG, TMAC-PEG and Ph-PEG hydrogels, obtained by fitting the release profiles with Eq. 2-1 
and Eq. 2-2, respectively. (*p < 0.05) (a,c) 10% PEGDA and 2% PEGMA, (b,d) 6% PEGDA and 6% 
PEGMA. ............................................................................................................................................. 20 
Figure 2-15. (a) Protein with pI higher than 7.4 becomes positively charged, and thus expected to have 
a greater release rate in TMAC-PEG hydrogels via repulsion than Sulfo-PEG hydrogels. The release 
profiles of trypsin from (b) Sulfo-PEG hydrogels, (c) TMAC-PEG hydrogels and (d) Ph-PEG 
hydrogels. (e) The kinetic rate constants (k) and (f) exponents (n) were values obtained by fitting the 
curves with Eq. 2-1. (g) Diffusion coefficient (D) were obtained by fitting the curves with Eq. 2-2. 
The PEGDA and PEGMA concentrations of the hydrogels were 8% and 4%, respectively. ............. 22 
Figure 2-16. (a,b) Kinetic rate constants (k) and (c,d) diffusion coefficients (D) of trypsin release from 
Sulfo-PEG, TMAC-PEG and Ph-PEG hydrogels, obtained by fitting the release profiles with Eq. 2-1 
IX 
 
and Eq. 2-2, respectively. (a) 10% PEGDA and 2% PEGMA, (b) 6% PEGDA and 6% PEGMA. .... 23 
Figure 3-1. A representative 1H-NMR spectrum of PEGDA. The peak integration ratio between acrylic 
peaks (a, b, c) and hydroxyethyl peak (d) are listed. .......................................................................... 27 
Figure 3-2. Schematic representation of in situ crosslinkable PEGDA-PEI hydrogels prepared under 
physiological condition. The reaction parameters include the concentrations of PEGDA and PEI as 
well as MW of PEGDA. ...................................................................................................................... 29 
Figure 3-3. The viscosity of PEI at various concentrations, measured at room temperature (RT) or 
37 °C. .................................................................................................................................................. 29 
Figure 3-4. (a) Photographic (top) and fluorescent microscopic (bottom) images of PEGDA-PEI 
hydrogels (scale bar: 100 μm). (A: 10 % PEGDA-5% PEI, B: 20 % PEGDA-5% PEI, C: 10 % 
PEGDA-3% PEI, D: 20 % PEGDA-3% PEI). (b) (Top) Photographs of PEGDA-PEI hydrogels 
conjugated with (E) or without (F) FITC after incubation in PBS. Greater swelling was observed for 
F due to accelerated degradation. (Bottom) After continuous swelling, F disintegrated while E 
remained intact. .................................................................................................................................. 30 
Figure 3-5. Rheological properties of the reaction mixture of 10% PEGDA and 5% PEI, evaluated by 
the changes in storage (G′) and loss (G″) moduli measured over time: (a) PEGDA400, (b) PEGDA700, 
(c) PEGDA1K, and (d) PEGDA2K. The arrows indicate the gel point. (e) The gelation times (tgel) of 
10% PEGDA or 20% PEGDA with 5% PEI. (f) tgel values of 20% PEGDA700 with varying 
concentration of PEI. .......................................................................................................................... 31 
Figure 3-6. Rheological properties of the reaction mixture of 10 % PEGDA and 5 % PEI, evaluated 
by the changes in storage (G’) and loss (G’’) moduli measured over time: (a) PEGDA3K and (b) 
PEGDA6K. ......................................................................................................................................... 31 
Figure 3-7. Rheological properties of the reaction mixture of 20 % PEGDA and 5 % PEI, evaluated 
by the changes in storage (G’) and loss (G’’) moduli measured over time: (a) PEGDA400, (b) 
PEGDA700, (c) PEGDA1K, (d) PEGDA2K, (e) PEGDA3K, and (f) PEGDA6K. The arrows indicate 
the gel point. ....................................................................................................................................... 32 
Figure 3-8. Rheological properties of the reaction mixture of 20 % PEGDA700 with (a) 3 % PEI, (b) 
5 % PEI, and (c) 10 % PEI. The changes in storage (G’) and loss (G’’) moduli were measured over 
X 
 
time. The arrows indicate the gel point. ............................................................................................. 33 
Figure 3-9. Elastic moduli (E) of PEGDA-PEI hydrogels: (a) 10% or 20% PEGDA with 5% PEI at 
varying MW of PEGDA, (b,c) 10% PEGDA or 20% PEGDA with varying PEI concentration and 
MW of PEGDA. (d) The ratio of the number densities of acrylate in PEGDA and amine in PEI (ФAc/Am) 
for varying MW of PEGDA at different PEI concentrations. .............................................................. 34 
Figure 3-10. Storage moduli (G′) of PEGDA-PEI hydrogels, taken from the highest G′ values 
after gelation from the rheological experiments. (a) 10% or 20% PEGDA with 5% PEI at varying 
MW of PEGDA and (b) 20% PEGDA700 with varying PEI concentration. ....................................... 36 
Figure 3-11. (a) Degradation mechanism of PEGDA-PEI hydrogels; hydrolysis of ester bonds by 
increased local hydroxide ions and/or direct nucleophilic attack on ester bonds by 
unreacted amine groups. (b) The change in normalized elastic moduli (E/E0) of 10% PEGDA-5% PEI 
hydrogels with varying MW of PEGDA plotted over time. (c) The degradation rate constants (kd) 
obtained by fitting (b) with Eq. 3-1. The kd values for (d) 10% PEGDA and (e) 20% PEGDA linked 
with varying concentrations of PEI. ................................................................................................... 37 
Figure 3-12. The change in normalized elastic moduli (E/E0) of 20 % PEGDA-5 % PEI hydrogels 
with varying MW of PEGDA plotted over time. The plots were fitted with Eq. 3-1 to obtain the 
degradation rate constants (kd) which are shown in Figure 3-11. ....................................................... 38 
Figure 3-13. (A) The drug release profiles of PEGDA-PEI hydrogels (10% PEGDA with 5% PEI). 
The profiles consisted of two separate modes of release occurring in sequence; initial swelling-
controlled mechanism, followed by degradation-controlled mechanism. (b) The initial drug release 
profiles were fitted with Eq. 3-2 and (c) the kinetic rate constants (k1) were obtained. (d) The latter 
drug release profiles were fitted with Eq. 3-3 and (e) the kinetic rate constants (k2) were obtained.. 40 
Figure 3-14. (a) The drug release profiles of PEGDA-PEI hydrogels (20 % PEGDA, 5 % PEI). The 
profiles consisted of two separate modes of release occurring in sequence; initial swelling-controlled 
mechanism, followed by degradation-controlled mechanism. (b) The initial drug release profiles were 
fitted with Eq. 3-2, and (c) the latter drug release profiles were fitted with Eq. 3-3. The k1 and k2 values 
obtained from (b) and (c) are shown in Figure 3-13........................................................................... 41 
Figure 3-15. k1 and k2 values obtained from drug release profiles of PEGDA-PEI hydrogels. (a,b) 10% 
PEGDA and (c,d) 20% PEGDA linked with varying concentrations of PEI. ..................................... 42 
XI 
 
Figure 3-16. The drug release profiles of PEGDA-PEI hydrogels. (a) 10 % PEGDA with 3 % PEI, (b) 
10 % PEGDA with 10 % PEI, (c) 20 % PEGDA with 3% PEI, (d) 20 % PEGDA with 10% PEI. .... 43 
Figure 4-1. (a) PEG grafting of chitosan (PEG-g-Cs). mPEG was first oxidized to present aldehyde 
groups (mPEG-aldehyde), which was then reacted with chitosan via Schiff base formation. Sodium 
cyanoborohydride was used to irreversibly reduce the Schiff base into secondary amine. (b) Schematic 
representation of in situ forming PEG-g-Cs hydrogel, with PEG-dialdehyde (PEGDAld) as a 
crosslinker. (c) FT-IR spectra of PEG750-g-Cs (a: vs(C-H), b: vs(C-O-O)(anti) (carboxylic acid 
salt), c: vs(C-N), d: vs(C-O-C)(anti)). (d) DSC curves of PEG750(0.7)-g-Cs and PEG2K(0.7)-g-Cs. (e) 
The microbial inhibition rates of PEG750(1)-g-Cs and PEG750(1)-g-Cs. ........................................ 46 
Figure 4-2. Representative 1H-NMR spectra of (a) N-carboxyethyl chitosan (NCE-Cs) and (b) PEG-
g-Cs. Characteristic peaks corresponding to N-carboxyethyl and PEG are assigned. ....................... 54 
Figure 4-3. FT-IR spectra of PEG2K-g-Cs. a: vs(C-H), b: vs(C-O-O)(anti) (carboxylic acid salt), c: 
vs(C-N), d: vs(C-O-C)(anti) ................................................................................................................. 55 
Figure 4-4. Representative DSC curves of (a) N-carboxyethyl chitosan (NCE-Cs) and (b) PEG-g-Cs. 
(c) Tm and ΔH of PEG chains obtained from the peaks corresponding to the melting of PEG chains on 
Cs. ....................................................................................................................................................... 55 
Figure 4-5. Anti-bacterial properties of (a) PEG750(1)-g-Cs and (b) PEG2K(1)-g-Cs at various 
concentrations by measuring the viability of E. coli over time. ......................................................... 56 
Figure 4-6. Elastic moduli (E) and swelling ratios (Q) of Cs-PEG hydrogels. (a, c) PEG750-g-Cs, (b, 
d) PEG2K-g-Cs. PEG-g-Cs was crosslinked by 20 % PEGDAld with varying MW. The PEG graft 
density and length, and the concentration of PEG-g-Cs were controlled. Possible physical interaction 
mechanisms between varying MW of PEGDAld with (e) PEG750-g-Cs and (f) PEG2K-g-Cs. ........ 58 
Figure 4-7. Elastic moduli (E) of Cs-PEG hydrogels. (a) 5 % PEG750(0.7)-g-Cs and (b) PEG2K(0.7)-
g-Cs crosslinked by PEGDAld with varying MW and concentration. ................................................ 60 
Figure 4-8. (a) Elastic moduli (E) of Cs-PEG hydrogels made by crosslinking NCE-Cs with varying 
MW of PEGDAld. (b) Possible mechanisms of PEGDAld interaction with PEG-g-Cs and NCE-Cs. 60 
Figure 4-9. (a) Scanning electron microscopic visualization of pore networks of Cs-PEG hydrogels 
XII 
 
(scale bar: 50 μm). (b-e) Cumulative amount of BSA release profiles from Cs-PEG hydrogels, and 
kinetic constants (k) and exponents (n) obtained by fitting the profiles with a mathematical model (Eq. 
4-2); (b, c) PEG750(0.7)-g-Cs crosslinked with varying MW of PEGDAld, (d, e) different types of 
PEG-g-Cs crosslinked with PEGDAld6K. ......................................................................................... 61 
Figure 4-10. E. coli growth on various Cs-PEG hydrogel surfaces, visualized by staining with MTT, 
which turns live bacterial cells brown-purple. LB agarose hydrogel was used as a control. ............. 63 
Figure 4-11. Rheological characterization of PEG-g-Cs and PEGDAld during gelation by measuring 
storage (G’) and loss (G’’): (a) PEG750(0.7)-g-Cs, (b) PEG2K(0.7)-g-Cs, (c) PEG750(1)-g-Cs, and 
(d) PEG2K(1)-g-Cs. In (c) and (d), PEGDAld6K was used. Gelation time for (e) PEG750-g-Cs and 
(f) PEG2K-g-Cs, determined by the time for G’ and G’’ curves to cross (identified with arrows). ... 64 
Figure 4-12. (a) Schematic illustrations of (a) a lap shear test and (b) a burst pressure test. Adhesive 
strength (σmax), adhesive energy (JA), and burst pressure (BP) of CsPEG hydrogels: (c, d, e) 
PEG750(0.7)-g-Cs and PEG2K(0.7)-g-Cs crosslinked with varying MW of PEGDAld, (f, g, h) 
PEG750(1)-g-Cs and PEG2K(1)-g-Cs crosslinked with PEGDAld6K. (*p < 0.05, n = 12). ............. 65 
Figure 4-13. (a) Cs-PEG hydrogel was applied to a rat skin wound model via syringe to close the 
wound gap. (b) OCT imaging was used to visualize the detailed skin tissue around the wound area. (c) 
After applying tissue sealants, the wound closure and subsequent healing process was monitored over 
time up to 5 days: (c-1) untreated, (c-2) suture, (c-3) Beriplast-P, (c-4) PEG750-g-Cs hydrogel, (c-5) 
PEG2K-g-Cs hydrogel, (c-6) PEG2K-g-Cs hydrogel encapsulated with EGF. The markers on OCT 
images identify the wound area. ......................................................................................................... 67 
Figure 4-14. The wound dimensions, width and depth, measured from the OCT images (marked with 
arrows in Figure 4-13) ........................................................................................................................ 68 
Figure 4-15. Detailed schematics of Swept-Source Optical Coherence Tomography (SS-OCT) 
imaging apparatus to visualized skin tissue; C: Collimator, L: Lens, RM: Reference mirror, FC: Fiber 
coupler, CIR: Circulator, BPD: Balanced photo-detector, GS: Galvanometer scanner. ..................... 68 
Figure 4-16. Histological evaluation of the skin wound tissues after tissue sealant treatment. The 
tissues harvested at day 3 and 5 were stained with hematoxylin & eosin (scale bar: 500 μm). E: 
epidermis, D: dermis, Sc: scab, arrows and highlighted area: fibrotic tissue. .................................... 69 
XIII 
 
Figure 5-1. 1H-NMR spectra of PEG-diamine with varying molecular weights; 200, 600, 1000 (1K) g 
mol-1. Characteristic peaks of ethylene oxide repeating are noted (a-c). .......................................... 73 
Figure 5-2. The amount of amine in (a) PEG-diamine and (b) PHEA-PEGAm600 with varying DSAm 
determined by TNBS assay (absorbance at 335 nm). ......................................................................... 74 
Figure 5-3. (a) Synthesis of poly(2-hydroxylethyl aspartamide)-g-amino-poly(ethylene glycol), 
termed PHEA–PEGAm, via ring-opening addition of polysuccinimide (PSI) with ethanolamine and 
PEG-diamine. (b) Synthesis of poly(ethylene glycol)(PEG) diamine via Mitsunobu reaction of PEG. 
(c) Schematic illustration of controlling the length and density of amine grafts of PHEA–PEGAm. 78 
Figure 5-4. 1H-NMR spectra of PHEA-PEGAm with varying DSAm; (a) PHEA-PEGAm200, (b) 
PHEAPEGAm600 and (c) PHEA-PEGAm1K. Characteristic peaks corresponding to hydroxyl grafts 
(a, c), amine grafts (b, d) and PEG linkers (e) are noted. ................................................................... 79 
Figure 5-5. Representative FT-IR spectra of PHEA-PEGAm with varying DSAm. Characteristic peaks 
corresponding to amide vs(C=O) of hydroxyl grafts (a) and amine grafts (b) are noted. .................. 80 
Figure 5-6. Cytotoxicity of PHEA-PEGAm assessed by measuring the viability of cells exposed to 
various concentrations of PHEA-PEGAm. ........................................................................................ 80 
Figure 5-7. Elastic moduli (E) of Alg-PHEA hydrogels controlled with DSAm of PHEA, (a) PHEA-
EtAm, (b) PHEA–PEGAm200, (c) PHEA–PEGAm600, and (d) PHEA–PEGAm1K. ..................... 81 
Figure 5-8. Schematic illustration of possible mechanisms of cross-linking reactions: (a) PHEA-EtAm 
or PHEA–PEGAm200 with varying DSAm; (b) PHEA–PEGAm with varying graft lengths. ............ 82 
Figure 5-9. Gelation time (tgel) of Alg-PHEA hydrogels controlled with concentration and DSAm of 
PHEA, (a) PHEA-EtAm, (b) PHEA–PEGAm200, (c) PHEA–PEGAm600, and (d) PHEA–PEGAm1K.
 ............................................................................................................................................................ 84 
Figure 5-10. Time-resolved fractional change in elastic moduli (Et/E0) and degradation rates (kD) of 
Alg-PHEA hydrogels: (a, d) PHEA–PEGAm200, (b, e) PHEA–PEGAm600, and (c, f) PHEA–
PEGAm1K. ........................................................................................................................................ 85 
Figure 5-11. Time-resolved fractional drug release profiles (Mt/M∞) and release rate constants (kR) of 
XIV 
 
Alg-PHEA hydrogels: (a, e) PHEA–PEGAm600 (DS4), (b, f) PHEA–PEGAm1K (DS4) with varying 
concentrations, (c, g) 15% PHEA–PEGAm600 with varying DSAm, and (d, h) 15% PHEA–PEGAm 
(DS4) with varying graft lengths. Elastic modulus (E) and degradation rate constant (kD) for each 
condition are noted. ............................................................................................................................ 86 
Figure 5-12. Exponent (n) values obtained by fitting the time-resolved drug releases of Alg-PHEA 
hydrogels with Eq. 5-2 (Ritger-Peppas model): (a) PHEA-PEGAm600 (DS4), (b) PHEA-PEG1K 
(DS4) with varying concentrations, (c) 15 % PHEA-PEGAm600 with varying DSAm, and (d) 15 % 
PHEAPEGAm (DS4) with varying graft lengths. .............................................................................. 87 
Figure 5-13. (a) Schematic representation of Alg-PHEA hydrogel injection into a tissue explant and 
subsequent degradation in neutral buffered solution. (b) Representative H&E histological images of 
Alg-PHEA hydrogel formed within tissue (left) and the same tissue area after hydrogel dissolution in 
24 h (right; scale bar: 100 μm). (c) H&E histological images (top) and photographs (bottom) of various 
Alg-PHEA hydrogels within tissues after 4 h (scale bar: 100 μm). Boxed sections in photographs show 
embedded hydrogels. .......................................................................................................................... 88 
Figure 5-14. (a) Elastic moduli and (b) SEM cross-sectional images of Alg-PHEA hydrogels further 
cross-linked with various concentrations of Ca2+ up to 5 M (scale bar: 30 μm). ............................... 89 
Figure 5-15. (a) Photographs of Alg-PHEA (control) and Ca-Alg-PHEA hydrogel disks, with the 
initial diameter of 8 mm, taken at various times during incubation in aqueous buffered solution. The 
concentration of Ca2+ cross-linker was controlled up to 5 M. The diameter before complete dissolution 
are noted. (b, c) Time-resolved fractional change in elastic moduli (Et/E0) and degradation rates (kD), 
and (d, e) time-resolved fractional drug release profiles (Mt/M∞) and release kinetics (kR) of Alg-PHEA 
and Ca-Alg-PHEA hydrogels (*p < 0.05). ......................................................................................... 90 
 
Table 3-1. The number densities (mol mL-1) of (a) acrylate in PEGDA and (b) amine in PEI at different 
concentrations. .................................................................................................................................... 35 




CHAPTER 1. Introduction 
1.1 Research Background 
Hydrogel for biomedical engineering 
Hydrogel is a three-dimensional (3D) network consisting of a group of hydrophilic polymers which 
that hold large amounts of water and can be extensively swelled with water. Due to their unique 
properties such as porosity, elasticity, biocompatibility and hydrophilicity are very similar to living 
tissue, they widely investigated as promising material for biomedical engineering application. [1-3] 
Currently, they are used for carrier for various biological molecules, tissue engineering scaffold, contact 
lens and wound dressings.  
Hydrogel networks are commonly formed through physical or chemical crosslinking of functional 
monomer. Physically cross-linked hydrogels possess temporary connections such as polymeric chain 
entanglement or physically induced gelation through hydrogen bonding, ionic interaction and 
hydrophobic interactions. These hydrogels are often called reversible gels, as they can be dissolved by 
changing environmental conditions (by pH, ionic strength, or temperature). Biomedical safety is a 
significant advantage of physical crosslinking, because the absence of chemical crosslinking agents can 
avoid the potential cytotoxicity of unreacted chemical crosslinkers. [4] These hydrogels can be obtained 
from poly(vinyl alcohol), poly(ethylene glycol), poly(Nisopropylacrylamide), poly(acrylic acid), 
poly(vinyl imidazole).  
Chemically cross-linked hydrogels are obtained through covalent bonds between polymer chains, and 
most of linkages are stable in physiological conditions and irreversible compared to physical 
crosslinked hydrogel. [4] Moreover, they exhibit good mechanical properties and adjustable 
decomposition behavior. Up to now, several crosslinking methods have been reported, generally include 
free radical polymerization and in situ crosslinking reaction such as Schiff base formation and Michael 
addition.  
Free radical polymerization is commonly used to form hydrogel. Because, it is highly reactive and 
tolerates variety of functional groups. Also, it occurs in mild conditions, even in aqueous solution and 
room temperature. Polymerization is usually initiated by free radical generating compound, radiation 
or heating. However, these activations and residual initiator often damage the cells and tissue. 
In situ crosslinked hydrogel can be prepared spontaneously without the use of initiator or harmful 
activation through chemical reactions between complementary functional groups. These reactions have 
advantages such as high yields under mild condition, low by-products, high specificity and selectivity.  
The Michael reaction typically refers to the addition of a nucleophile (Michael donors) to an activated 
α,β-unsaturated carbonyl-containing compound (Michael acceptors). [5, 6] This reaction benefits from 
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mild reaction conditions, various compatible reagents, high conversions, and the absence of side-
products or toxic metal catalysts. Accordingly, this reaction is well-suited for gene transfection, cellular 
scaffold and tissue replacement and widely exploited for the preparation of injectable hydrogels for 
biomedical applications.  
A Schiff base is usually formed by condensation of an aldehyde or ketone with a primary amine such 
as HA, chitosan, and dextran under physiological conditions. In general, depending on the ratio of amine 
to aldehyde groups, their gelation time and physical properties can be varied. It can be easily applied to 
construction of an injectable hydrogel due to aldehyde groups can react with other amine groups in 
tissue or organs. The dynamic equilibrium between Schiff base bonds and aldehyde and amine reactants 
provides advantages for Schiff base formation and provides self-healing capabilities of the hydrogel 
network through reversible reactions such as uncoupling and recoupling of imine bonds. 
1.2 Research Purpose and Motivation 
Currently, hydrogels are applied in many important biomedical applications such as therapeutic 
delivery, contact lenses, corneal prosthetics, bone cement, wound dressing, 3D tissue scaffolds for tissue 
engineering, and more. However, their properties, such as low mechanical strength, antimicrobial, 
biological interactions, water sorption and diffusion, degradation and others, are often hindered to use 
in biomedical application. Moreover, it is difficult to control properties effectively because of their 
interdependent properties as well as their fabrication mechanisms which cause toxicity. Therefore, it is 
important to control these properties at various levels while maintaining their unique properties to meet 
the specific requirements. 
Herein, we have developed advanced hydrogels with controllable physicochemical properties, as 
multifunctional systems, which are expected to exhibit superior properties to increase the potential uses 
of these materials in the biomedical industry. 
3 
 
CHAPTER 2. Modulation of functional pendant chains within 




Hydrogels are a popular class of carriers for various biological molecules, such as proteins and DNA, 
as well as cells and tissues for biomedical applications. [7-10] Highly favorable physical properties of 
hydrogels prepared using biocompatible polymers, such as elasticity and hydrophilicity, help provide 
the encapsulated entities with optimal mechanical and aqueous environment and protection for 
prolonged life-time. In addition, the fabrication methods are generally mild enough to allow for safe 
encapsulation with high efficiency. The cellular activities within the hydrogels could be further 
promoted by modifying the polymer network with cell-responsive moieties. [11, 12] 
For controlled release applications, the release rates of encapsulated biomolecules from hydrogels are 
often controlled in an efficient manner by simply varying the crosslinking density of the polymeric 
network, which in effect controls the porosity of the hydrogel. [13-15] However, this approach is also 
often encountered with a few critical drawbacks. First, the crosslinking density, according to the rubber 
elasticity theory, also affects the mechanical properties of the hydrogels, in which the mechanical and 
diffusional properties are inversely correlated. [16, 17] Thus, this interdependency could lead to an 
inadvertent change in mechanical properties while attempting to control the release rates via 
crosslinking density; hydrogels may become structurally too weak at lower crosslinking density to 
increase the release rate, or they may become too brittle at higher crosslinking density. Furthermore, the 
release may be severely hindered for the hydrogel having significantly reduced pores, which is 
especially critical for the release of larger macromolecules such as large proteins and DNA. [14, 18] To 
overcome these issues, it would be ideal to control the release rates of encapsulated species in a wide 
range while minimally affecting the crosslinking density of the hydrogels. 
In this study, protein release rates from hydrogels were controlled by varying the physical properties 
of the hydrogels while maintaining their crosslinking density. Poly(ethylene glycol) dimethacrylate 
(PEGDA) hydrogels presenting pendant chains with end functional groups with varying physical 
properties (i.e. charge density and hydrophobicity) were fabricated by radical copolymerization with 
heterobifunctional PEG monomethacrylate (PEGMA) (Figure 2-5a). There have been previously 
published reports of engineering charged or hydrophobic hydrogels, but their approaches generally 
involved utilizing the monomers or macromers with charged or hydrophobic functional domains (e.g. 
acrylate, vinyl sulfonate, [2-(methacryloxy)ethyl] trimethylammonium chloride), poloxamers, and 
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heparin), and thus maintaining their crosslinking densities were not factored. [19-25] However, in this 
study, by changing the number of “functional” pendant chains while keeping the total number of 
pendant chains constant, the crosslinking density of the PEG hydrogels could be controlled, thereby 
minimally affecting the mechanical properties, while varying the physical properties of the hydrogels. 
With PEG pendant chains with charged functional groups, (e.g. negatively charged sulfonate and 
positively charged trimethylammonium chloride), the release of proteins having different charge 
densities at physiological pH due to different isoelectric points (pI) could be controlled via electrostatic 
interaction. Three model proteins, namely albumin, insulin and trypsin, having different pI values, were 
used. Their release rates from the PEG hydrogels with varying number of charged pendant chains were 
measured. Furthermore, since proteins have varying degrees of hydrophobicity based on amino acid 
compositions, the release from PEG hydrogels with hydrophobic phenyl pendant chains was also 
explored. 
 
2.2 Materials and Methods 
2.2.1 Synthesis of Poly(ethylene glycol) dimethacrylate (PEGDA) 
PEGDA was synthesized following a previously published method. [26] Briefly, poly(ethylene 
glycol) (PEG, average MW of 2,000 g mol−1, Sigma Aldrich) and triethylamine (Sigma Aldrich) were 
first dissolved in dichloromethane. Methacryloyl chloride (Sigma Aldrich) was added dropwise to the 
mixture, and continuously stirred for 24 hours under dry N2 gas. The molar ratio of PEG, methacryloyl 
chloride and triethylamine was 1:4:5. The insoluble salt formed during the reaction was filtered out, 
and excess diethyl ether was added to the mixture to precipitate the product. The product was obtained 
by filtration, washed twice with diethyl ether, and dried under vacuum. 
 
2.2.2 Synthesis of heterobifunctional poly(ethylene glycol) monomethacrylate (PEGMA) 
Heterobifunctional PEGMA having a functional end group was developed by two-step synthesis: (1) 
the ring-opening anionic polymerization of ethylene oxide to synthesize heterobifunctional PEG, 
followed by (2) the conjugation of methacrylate onto the hydroxyl group on the PEG (Figure 2-5b). 
[26-28] 
Potassium naphthalenide, a strong base that activates the hydroxyl-based initiator to alkoxide, was 
prepared by dissolving molar equivalents of potassium and naphthalene (9 mmol each) in 20 mL of dry 
tetrahydrofuran (THF, Samchun Chemical, Korea) for 5 hours. The mixture became dark green with 
the formation of potassium naphthalenide. Hydroxyl-based initiator (11 mmol) was dissolved 
separately in 30 mL of dry THF, and the potassium naphthalenide mixture was slowly added and stirred 
for one hour, resulting in the alkoxide formation. 30 mL of ethylene oxide (EO, Asia Chemical, Korea) 
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was then added to the mixture and continuously stirred for 48 hours at room temperature (note: the 
mixture and EO was chilled on ice to prevent evaporation during the mixing process). The entire 
process was done under dry N2 gas. 
HCl (10 mmol) was added to stop and neutralize the reaction, from which the insoluble salt (KCl) 
being formed was filtered out. After condensing the mixture via rotary evaporation, the crude product 
was obtained by precipitation in excess diethyl ether. After washing with diethyl ether twice, the final 
product was obtained by filtration and drying under vacuum. The initiators used for synthesizing 
sodium sulfoethyl, trimethylammonium chloride, and phenyl-capped PEG, namely Sulfo-PEG, 
TMAC-PEG, and Ph-PEG, were sodium isethionate, choline chloride, and 2-phenylethanol (all 
purchased from Sigma Aldrich), respectively. The molecular weights (MW) of Sulfo-PEG, TMAC-PEG, 
and Ph-PEG, as determined from MALDI-TOF mass spectrometry (Ultraflex III, Bruker), were 2341, 
2200, and 1770 g mol−1, respectively (Figure 2-1). For Sulfo-PEG and TMAC-PEG, tetrahydrofuran 
and 2,5-dihydroxybenzoid acid (Sigma Aldrich) were used as solvent and matrix, respectively, while 
chloroform and dithranol (Sigma Aldrich) were used for Ph-PEG. 
 
Figure 2-1. The molecular weight distributions of (a) Sulfo-PEG, (b) TMAC-PEG, and (c) Ph-PEG, 
determined from MALDI-TOF mass spectrometry. 
The conjugation of methacrylate was done using the same procedure for the synthesis of PEGDA. 
The molar ratio of heterobifunctional PEG, methacryloyl chloride and TEA here was 1:2:3, as there is 
only one hydroxyl group in a polymer chain. 
The chemical structures of the heterobifunctional PEGMAs were analyzed with 1H-NMR and 13C-
NMR spectra (400-MR DD2, Agilent) (Figure 2-2 and Figure 2-3). The MW of Sulfo-PEGMA, TMAC-
PEGMA and Ph-PEGMA, determined by the ratio of integration peaks corresponding to methacrylate 
and ethylene oxide unit, were 3370, 3211, and 4120 g mol−1, respectively. The zeta potentials of 
sulfonate and trimethylammonium chloride linked PEG were determined at 0.1 wt% in 10 mM NaCl, 












Figure 2-4. Zeta potential values of (a) proteins (albumin, insulin, and trypsin) and (b) SulfoPEGMA 
and TMAC-PEGMA, measured at 0.1 % (w/v) in 10 mM NaCl. 
2.2.3 Fabrication of hydrogels  
A precursor solution was prepared by mixing PEGDA and PEGMA in various ratios, while keeping 
the overall concentration at 12% (w/v). The total PEGMA content consisted of ‘non-functional’ 
methoxy PEGMA (Mn 2000 g mol−1, Sigma Aldrich) and the heterobifunctional PEGMA. At a given 
PEGMA concentration, the fraction of heterobifunctional PEGMA was varied to control the physical 
properties of the pendant PEG chains. 10 μL of ammonium persulfate (1 M) and 1 μL of 
tetramethylethylenediamine as co-initiators were added to 1 mL of a precursor solution, and placed 
in a custom-made mold with 1 mm spacer to prepare disk-shaped hydrogels with a diameter of 
8 mm. The hydrogel disks were incubated in phosphate buffered saline (PBS) at room temperature 
for 24 hours before mechanical characterization. 
 
2.2.4 Evaluation of mechanical properties of hydrogels 
The mechanical properties of hydrogels were evaluated by calculating elastic moduli from stress-
strain curves obtained from uniaxial compression experiments (Model 3343, Instron). [29-31] Each 
hydrogel disk was compressed at a rate of 1 mm min−1. The elastic modulus was calculated from the 
slope of a stress-strain curve at the initial 10% strain region where the curve was linear. 
 
2.2.5 Evaluation of protein release from hydrogels 
The effect of physical properties of hydrogels on drug release kinetics was evaluated by measuring 
time-dependent release profiles of proteins with varying pI values. Albumin (from human serum, Sigma 
Aldrich), trypsin (from bovine pancreas, Sigma Aldrich) and insulin (human recombinant, Sigma 
Aldrich) having pI values of 4.7, 5.3, and 10.5, respectively, were used as model proteins. Their zeta 
potentials were measured at −14.2 mV, −5.7 mV, and 22.1 mV, respectively (0.1 wt% in 10 mM NaCl, 
pH 7) (Figure 2-4). The protein was first encapsulated into the hydrogel by dissolving the protein 
(2 mg mL−1) in a precursor solution prior to fabrication. The hydrogel disks were prepared as mentioned 
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above. The hydrogel disks were incubated in PBS at 37 °C, and at each designated time point, the 
incubating media were collected and the protein concentrations were obtained using BCATM Protein 
Assay kit (Thermo Fisher), following the manufacturer’s instructions. The cumulative protein release 
profiles were fitted to the Ritger-Peppas equation, 
𝑀𝑡
𝑀∞
= 𝑘 ∙ 𝑡𝑛    Eq. 2-1 
where M t was the cumulative amount of protein released at a time, t, M ∞ was the total amount of 
protein in the hydrogel, k was the kinetic rate constant, and n is the exponent related to the release 
mechanism. [26, 30, 32] 
Alternatively, the cumulative protein release profiles were fitted to the following power-law equation 






)1/2    Eq. 2-2 
where D was the diffusion coefficient and h was the thickness of the hydrogel disk samples. [33-35] 
This relationship generally fits well for the first 60% of the release due to the fixed time dependency 
(t1/2). 
 
2.3 Results and Discussion 
2.3.1 Synthesis of heterobifunctional PEGMA 
PEG hydrogels have long been used as drug delivery systems due to biocompatibility, abundant source, 
bioinertness, and efficient processing. [12, 36] In particular, PEG with vinyl end groups, such as 
PEGDA, are widely used to develop hydrogels via radical polymerization either by itself or hybridizing 
with other vinyl-based polymers. The drug release rates from PEG hydrogels can be accomplished by 
controlling the crosslinking density which in turn controls the porosity of the polymeric network. [13, 
14, 37] The physical properties of the PEG hydrogels can be further varied by introducing different 
moieties into the PEG network; copolymerization with other polymers or hybridizing with 
nanostructures (i.e. nanocomposite hydrogels). [38, 39] However, these strategies are often 
accompanied by unwanted changes in mechanical and swelling properties of the hydrogels, which may 
complicate the control of drug release. 
Here, PEG hydrogels presented with varying number of pendant PEG chains with functional end 
groups were developed by copolymerizing PEGDA with heterobifunctional PEG monomethacrylate 
(PEGMA) to control the physical properties (e.g. charge density and hydrophobicity) while maintaining 
the crosslinking density (Figure 2-5a). By keeping the number of pendant chains, it would prevent 




Three different types of heterobifunctional PEGMA was synthesized; sodium sulfoethyl PEGMA 
(Sulfo-PEGMA), trimethylammonium chloride PEGMA (TMAC-PEGMA), and phenyl PEGMA (Ph-
PEGMA) in order to impart negative charge, positive charge and hydrophobicity, respectively (Figure 
2-5b). The ring-opening polymerization of epoxide with the anionic initiator having the desired 
functional group was employed to synthesize the heterobifunctional PEG, which was followed by the 
conjugation of methacrylate via nucleophilic substitution of the hydroxyl group of PEG using 
methacryloyl chloride. The chemical compositions of various heterobifunctional PEGMA were 
confirmed with 1H-NMR and 13C-NMR (Figure 2-2 and Figure 2-3). The zeta potentials of Sulfo-
PEGMA and TMAC-PEGMA were also determined to be −0.208 mV and 0.11 mV (0.1 wt% in 10 mM 
NaCl), respectively, which further confirmed the difference in the type and density of charges (Figure 
2-1). 
 
Figure 2-5. (a) Fabrication of PEG hydrogels with functional pendant chains via radical 
copolymerization of PEGDA with heterobifunctional PEGMA. (b) Synthesis of heterobifunctional 
PEGMA via anionic polymerization of epoxide with an initiator containing the desired functional group, 
followed by the conjugation of methacrylate. The functional groups used in this study were sulfonate 
(negative charge), trimethylammonium chloride (positive charge) and phenyl (hydrophobicity) groups. 
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2.3.2 Mechanical properties of PEG hydrogel with functional pendant chains 
In order to control the physical properties of PEG hydrogels while minimizing the difference in 
crosslinking density among different pendant chains, the total number of pendant chains were kept 
constant while varying the fraction of functional pendant chains (Φ) (Figure 2-6a). This was 
accomplished by varying the ratio of heterobifunctional PEGMA with methoxy PEGMA as a non-
functional control, while keeping the total concentration of PEGMA in a precursor solution (e.g. Φ = 0 
when all the pendant chains are non-functional, Φ = 1 when all the pendant chains are functional). 
The rigidity of the PEG hydrogels with varying Φ was measured to assess the effect of functional 
pendant chains. The concentrations of PEGDA and PEGMA were first kept at 10% and 2% (w/v) 
respectively. Increasing Φ did not result in a significant change in elastic moduli of the hydrogels, and 
the moduli at a given Φ were similar for all types of pendant chains (Figure 2-6b, Figure 2-7). This 
result demonstrated that the crosslinking density of hydrogels at varying Φ was not significantly 
affected for all types of pendant chains at the given PEGDA and PEGMA concentrations. 
 
Figure 2-6. (a) The fraction of functional pendant chains (Φ) was varied while keeping the total number 
of pendant chains constant. Normalized elastic moduli (E/E0) of PEG hydrogels with varying Φ, 
measured (b,c,d) right after fabrication and (e,f,g) after incubation in PBS for 24 hours. The moduli 
were normalized with that at Φ = 0 (E0). (b,e) 10% PEGDA and 2% PEGMA, (c,f) 8% PEGDA and 4% 




Figure 2-7. Elastic moduli (E) of Sulfo-PEG, TMAC-PEG, and Ph-PEG hydrogels measured right after 
fabrication (‘initial moduli’). The PEGDA and PEGMA concentrations of the hydrogels were (a) 10% 
and 2%, (b) 8% and 4%, and (c) 6% and 6%. 
The relative concentrations of PEGDA and PEGMA were varied to further evaluate the possible 
change in crosslinking density by varying Φ; the PEGMA concentration was increased to 4% and 6% 
(w/v) while decreasing PEGDA concentration to 8% and 6% (w/v), thus keeping the total polymer 
concentration at 12% (w/v). Since the PEGDA molecules are mainly responsible for the crosslinking 
of the polymeric network, the overall elastic moduli became smaller at higher PEGMA concentrations 
(Figure 2-7). There was a small decrease in moduli above Φ = 0.5 for Sulfo-PEG and TMAC-PEG 
hydrogels, and the decrease became larger at higher PEGMA concentration (e.g. 15% and 25% 
decreases at Φ = 1 for 4% and 6% PEGMA, respectively) (Figure 2-6c and d, Figure 2-8). This result 
may have been due to the increased charge density pushing the polymer chains further apart via 
repulsion, leading to a diminished degree of crosslinking. It is further corroborated by the lack of 
change in moduli of uncharged Ph-PEG hydrogels regardless of Φ and PEGMA concentration. 
Scanning electron microscopic (SEM) images of the hydrogels with 2% and 4% PEGMA also showed 
that the porosity, which generally correlates with the crosslinking density, was not significantly affected 
by the type of pendant chains at a given Φ (Figure 2-9). [29, 40] Taken together, except at the higher Φ 
of Sulfo-PEG and TMAC-PEG hydrogels with lower crosslinking density (i.e. higher PEGMA 
concentration), the mechanical properties of the hydrogels were generally well maintained at varying 
Φ. Even in those conditions, the crosslinking densities of Sulfo-PEG and TMAC-PEG hydrogels at a 
given Φ were similar, and thus the protein release from the two hydrogel systems could be analyzed 




Figure 2-8. (a-c) Elastic moduli (E) and (d-e) swelling ratios (Q) of Sulfo-PEG, TMAC-PEG, and Ph-
PEG hydrogels. The PEGDA and PEGMA concentrations of the hydrogels were (a,d) 10% and 2%, (b,e) 
8% and 4%, and (c,f) 6% and 6%. E and Q were measured after 1 day of incubation in PBS. 
 
Figure 2-9. Scanning electron microscopic (SEM) images of non-functional mPEG hydrogel, Sulfo-
PEG hydrogel, TMAC-PEG hydrogel, and Ph-PEG hydrogel at Φ = 1 (scale bar: 5 μm). (a) 10% 
PEGDA and 2% PEGMA, (b) 8% PEGDA and 4% PEGMA. 
Next, the moduli of the hydrogels were measured after incubation in PBS in order to evaluate the 
effect of swelling into hydrogels controlled by different charge densities (Figure 2-6e-g). It was 
hypothesized that the decrease in moduli by the swelling would be varied by the type and density of 
charge within the hydrogels. The moduli of Ph-PEG hydrogels were not affected by Φ, as expected, 
regardless of the concentrations of PEGDA and PEGMA, due to the lack of charge. However, the 
decrease in moduli of Sulfo-PEG hydrogels by Φ became more prominent with decreasing PEGDA 
(increasing PEGMA), especially more so than TMAC-PEG hydrogels. For example, the moduli of 
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Sulfo-PEG hydrogels decreased with Φ by 60% and 85% for hydrogels with 8% PEGDA and 4% 
PEGMA and 6% PEGDA and 6% PEGMA, respectively. On the other hand, the moduli of TMAC-
PEG hydrogels decreased with Φ only by 40% and 50% for hydrogels with 8% PEGDA and 4% 
PEGMA and 6% PEGDA and 6% PEGMA, respectively. These results indicated that (1) the increased 
charge density within the Sulfo-PEG hydrogels and TMAC-PEG hydrogels with increasing Φ likely 
pushed the polymer chains further apart via repulsion during swelling and resulted in greater chain 
relaxation, and (2) the larger decrease in moduli for Sulfo-PEG hydrogels compared to TMAC-
hydrogels is likely due to the greater charge density of the Sulfo group compared to TMAC groups, as 
evidenced by their zeta potentials. [41, 42] 
The trends of swelling ratios of PEG hydrogels with functional pendant chains were in conjunction 
with those of elastic moduli shown in Figure 2-6, as expected, since the degree of swelling and rigidity 
are inversely related according to the rubber elasticity theory (Figure 2-10). Interestingly, the swelling 
ratios of TMAC-PEG hydrogels were not significantly affected by Φ especially compared to the 
decrease in moduli. It is likely a result of smaller ionic strength and increased local hydrophobicity by 
the methyl groups in TMAC, preventing further swelling behavior. This is further highlighted in 
comparison with the Sulfo-PEG hydrogels, which do not have hydrophobic groups and have greater 
ionic strength than TMAC, showing much greater increase in swelling ratios with Φ. 
 
Figure 2-10. Normalized swelling ratios (Q/Q0) of PEG hydrogels with varying Φ. The swelling ratios 
were normalized with that at Φ = 0 (Q0). (a) 10% PEGDA and 2% PEGMA, (b) 8% PEGDA and 4% 
PEGMA, (c) 6% PEGDA and 6% PEGMA. 
2.3.3 Protein release from PEG hydrogel with functional pendant chains 
Three proteins having different isoelectric points (pI), albumin, insulin, and trypsin, were used as 
model protein drugs, and their release profiles from the PEG hydrogels with varying Φ were measured. 
Albumin and insulin have the pI values of 4.9 and 5.3, so they are expected to be negatively charged at 
the physiological pH of 7.4. The pI of trypsin, on the other hand, is 10.5, thus it would be positively 
charged at the physiological pH. By comparing their release profiles, the effect of charge type and 
density in the hydrogels could be evaluated. Furthermore, between albumin and insulin, their molecular 
weights are 66 kDa and 5.8 kDa, respectively, so the effect of the size of the protein on the release could 
15 
 
also be determined. The protein release profiles with respect to time was then fitted with either (1) the 
Ritger-Peppas model in order to obtain the kinetic rate constants (k) and exponents (n) (Eq. 2-1), or the 
Fickian diffusion model to obtain diffusion coefficients (D) (Eq. 2-2), in order to analyze the drug 
release kinetics. Compared to the traditional Fickian diffusion model which is based on a fixed square 
root dependence on time, the Ritger-Peppas model allows the determination of both kinetic rate 
constant and power-law dependence on time. [43] The exponents indicate the release mechanism which 
depends heavily on the permeability and physical characteristics (e.g. chain relaxation) of the drug 
carriers. For hydrogels which undergo significant swelling due to the osmotic pressure from the 
surrounding medium as well as the chain relaxation of the polymeric network, the Fickian diffusion 
model is often limited when describing the overall release profiles (i.e. this model is more accurate at 
the initial protein release in which the release is mostly governed by the diffusion, whereas the release 
by chain relaxation deviates from the square root time dependence). 
Albumin. Albumin is the most abundant type of protein commonly found in the plasma of most 
mammalian species, responsible for the transport of various molecules and maintaining the oncotic 
pressure. [44] It is negatively charged at physiological pH due to its lower pI value of 4.9. Therefore, 
the albumin encapsulated in Sulfo-PEG hydrogel was expected to have higher release rates than that 
of TMAC-PEG hydrogels due to electrostatic repulsion (Figure 2-11a). The albumin release profiles 
from Sulfo-PEG hydrogels and TMAC-PEG hydrogels were measured (Figure 2-11b and c), and the 
kinetic rate constants (k) were obtained via Ritger-Peppas model (Figure 2-11e). The concentrations of 
PEGDA and PEGMA were first kept at 8% and 4%, respectively. As expected, the k values of Sulfo-
PEG hydrogels increased with Φ, and were significantly larger than those of TMAC-PEG hydrogels at 
all Φ, demonstrating that the increased negative charge by Sulfo-PEG facilitated the release of albumin 
(Figure 2-11e). Although the k values in TMAC-PEG hydrogels were lower than those of Sulfo-PEG 
hydrogels, increasing Φ did not result in the decrease of k values via electrostatic attraction as expected, 
likely due to the lower charge density of TMAC-PEG compared to Sulfo-PEG (i.e. TMAC-PEG has 





Figure 2-11. (a) Protein with pI lower than 7.4 becomes negatively charged, and thus expected to have 
a greater release rate in Sulfo-PEG hydrogels via repulsion than TMAC-PEG hydrogels. The release 
profiles of albumin from (b) Sulfo-PEG hydrogels, (c) TMAC-PEG hydrogels and (d) Ph-PEG 
hydrogels. (e) The kinetic rate constants (k) and (f) exponents (n) were obtained by fitting the curves 
with Eq. 2-1. (g) Diffusion coefficients (D) were obtained by fitting the curves with Eq. 2-2. The 
PEGDA and PEGMA concentrations of the hydrogels were 8% and 4%, respectively. (*p < 0.05). 
17 
 
The release profiles and their k values of albumin from PEG hydrogels with phenyl groups (Ph-PEG) 
were also obtained not only as a control to the Sulfo-PEG and TMAC-PEG hydrogels but also as a 
hydrogel with hydrophobicity (Figure 2-11d and e). The k values of Ph-PEG hydrogels at each Φ was 
in between those of Sulfo-PEG and TMAC-PEG hydrogel, demonstrating their charge neutrality. The 
values were not as significantly influenced by the increase in Φ, which showed the increase in 
hydrophobicity had little effect on the interaction between albumin and the polymeric network. 
The exponents (n) from the Ritger-Peppas models were between 0.3 and 0.4 for all conditions, 
indicating the drug release was governed mostly by the Fickian diffusion and the release mechanism 
was not affected by the type of pendant functional groups (Figure 2-11f). [26, 33, 45] However, the 
release mechanism here showed smaller time-dependency (e.g. greater initial release) than a pure 
Fickian diffusion (i.e. the n value for a pure Fickian diffusion is 0.5). This ‘quasi’ Fickian diffusion 
mechanism suggested that the presence of more freely moving pendant chains, as compared to fully 
linked chains with limited mobility, likely promoted the faster drug release than what would be 
expected for the pure Fickian diffusion. 
The drug release profiles were alternatively fitted with a Fickian diffusion model (Eq. 2-2) which 
assumes the square root of time dependence (~t1/2), and obtained the diffusion coefficients (D) (Figure 
2-11g). Because of the greater time dependence, the Fickian diffusion model did not ft well after first 
10 hours of release (i.e. approximately 60% of total release) and overestimated the D values compared 
to k values from the  Ritger-Peppas model. [34] Nonetheless, the trend in D values were similar to that 
of k values shown in Figure 2-11e, as they were expected to correlate with each other if n values from 
the Ritger-Peppas model were close to 0.5 and similar among different conditions. 
The albumin release from PEG hydrogels at different PEGMA concentrations were further evaluated 
to assess the effect of crosslinking density on the protein release (Figure 2-12). When the PEGMA 
concentration was lowered to 2% (w/v) (PEGDA concentration increased to 10% (w/v)), 
the k and D values were generally low for all hydrogel types (Figure 2-12a and c). In addition, there 
was also negligible effect of Φ on the k values. This result suggests that albumin release was 
significantly hindered by the diminished porosity of the hydrogels at higher crosslinking density, and 
as a result the effect of charged groups on albumin release became minimal. When the PEGMA 
concentration was increased to 6% (w/v) (PEGDA concentration decreased to 6% (w/v)), there was a 
substantial increase in k and D values with Φ for all types of hydrogels (Figure 2-12b and d). The 
albumin release from Sulfo-PEG hydrogels was larger than other hydrogels, as expected. But there 
were smaller increases in albumin release from TMAC-PEG hydrogels and Ph-PEG hydrogels with Φ, 
despite the increasing positive charge and hydrophobicity. This is due to the increased porosity of the 
hydrogels, as evidenced by the swelling ratio shown in Figure 2-10, facilitating the protein release from 




Figure 2-12. (a,b) Kinetic rate constants (k) and (c,d) diffusion coefficients (D) of albumin release from 
Sulfo-PEG, TMAC-PEG and Ph-PEG hydrogels, obtained by fitting the release profiles with Eq. (1) 
and Eq. 2-2, respectively. (*p < 0.05) (a,c) 10% PEGDA and 2% PEGMA, (b,d) 6% PEGDA and 6% 
PEGMA. 
Insulin. Insulin, a hormone produced by beta cells in pancreatic islets, regulates the glucose level in 
our body. It is the de facto glucose-lowering drug for diabetes, and biomaterial-based delivery systems 
have been widely investigated for its controlled release. [46] It has a pI value of 5.3, thus possessing 
negative charge at physiological pH, much like albumin. But since insulin (5.8 kDa) is much smaller 
than albumin (66 kDa), it was hypothesized that the level of control of insulin release from the charged 
PEG hydrogels would be different from that of albumin. 
 The concentration of PEGMA was first kept at 4% (w/v) (PEGDA concentration of 8% (w/v)). 
The k values of insulin in Sulfo-PEG hydrogels began to increase significantly when Φ was increased 
above 0.5, unlike the albumin whose release was promoted below 0.5 (Figure 2-13a and d). Since there 
is less positive charge on insulin than albumin due to higher pI, more negative charges may have been 
needed to facilitate the release. It is also possible that the smaller size of insulin likely conferred more 




Figure 2-13. The release profiles of insulin from (a) Sulfo-PEG hydrogels, (b) TMAC-PEG hydrogels 
and (c) Ph-PEG hydrogels. (d) The kinetic rate constants (k) and (e) exponents (n) obtained by fitting 
the curves with Eq. 2-1. (f) Diffusion coefficients (D) were obtained by fitting the curves with Eq. 2-2. 
(*p < 0.05) The PEGDA and PEGMA concentrations of the hydrogels were 8% and 4%, respectively. 
More significantly, the k values of insulin in TMAC-PEG hydrogels decreased above Φ = 0.5, 
demonstrating the increased positive charge helped delay the release of insulin, more so than albumin 
despite less negative charge (Figure 2-13b and d). The smaller insulin likely was better able to interact 
with TMAC groups than bulkier albumin. The release from hydrophobic Ph-PEG hydrogels also 
showed significant decrease with Φ, demonstrating the increased number of phenyl groups was able to 
undergo extensive hydrophobic interaction with insulin, thereby delaying the release. Compared to 
albumin, less negative charge and smaller size of insulin likely contributed to this phenomenon. 
 Like albumin, the exponents (n) of insulin release from the hydrogels were all below 0.5, indicating 
the quasi-Fickian release with greater initial release (Figure 2-13e). However, the n values from Sulfo-
PEG hydrogels were significantly lower than those of TMAC-PEG and Ph-PEG hydrogels, which 
further highlight the much accelerated release of insulin from the Sulfo-PEG hydrogels as compare 
with other hydrogels, likely attributed to the smaller size compared to albumin. In addition, similar to 
the albumin release, the changes in diffusion coefficients (D) calculated from fitting with Eq. 2-2 with 
Φ and type of pendant chains were generally in line with the k values shown in Figure 2-13d obtained 
from Eq. 2-1 (Figure 2-13f). 
 As similarly done with albumin, the insulin release from hydrogels were evaluated at different 
PEGMA concentrations to assess the effect of crosslinking density (Figure 2-14). Interestingly, when 
the PEGMA concentration was reduced to 2% (w/v) (increasing PEGDA concentration to 10% (w/v)), 
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the k and D values of insulin from Sulfo-PEG hydrogels showed significant increase with Φ up to 0.5, 
but decreased with Φ afterwards (Figure 2-14a and c). Similarly, to lesser extent, the release profiles 
of TMAC-PEG hydrogels and Ph-PEG hydrogels followed the similar patterns. This biphasic behavior 
was not shown for albumin at the same PEGMA concentration in Figure 2-12, in which the overall 
release was diminished, and suggested that there is an optimal level of diffusion of smaller protein in a 
more crosslinked network. The initial increase in k values with Φ up to 0.5 could possibly be a result 
of insulin, which is much smaller than albumin, being able to diffuse from the hydrogels even through 
diminished porosity at higher crosslinking density via pressure-driven flow enhancement in confined 
spaces. [47, 48] However, further increase in Φ likely reduced the flow enhancement, as the increased 
functional groups facilitated the increased porosity via the polymeric chain relaxation, eliminating the 
pressure gradient within the hydrogel. This interesting aspect of protein release in confined polymeric 
networks warrants further investigation in future studies. 
 
Figure 2-14. (a,b) Kinetic rate constants (k) and (c,d) diffusion coefficients (D) of insulin release from 
Sulfo-PEG, TMAC-PEG and Ph-PEG hydrogels, obtained by fitting the release profiles with Eq. 2-1 
and Eq. 2-2, respectively. (*p < 0.05) (a,c) 10% PEGDA and 2% PEGMA, (b,d) 6% PEGDA and 6% 
PEGMA. 
For the hydrogels with higher PEGMA concentration of 6% (w/v) (the PEGDA concentration of 6% 
(w/v)), the overall k and D values were much larger than those at lower PEGMA concentrations, as 
expected, due to lower crosslinking density (Figure 2-14b and d). The k values of Sulfo-PEG hydrogels 
remained high at all Φ, suggesting the increased negative charge density did not contribute to the release 
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rates as they were already high. On the other hand, the k values of TMAC-PEG hydrogels decreased 
with Φ, demonstrating the enhanced electrostatic interaction with insulin by the increased positive 
charge density helped delay the release. The increased hydrophobic interaction by increasing Φ of Ph-
PEG hydrogels also resulted in decreasing k values. Interestingly, the increase in D for Sulfo-PEG 
hydrogels with Φ was larger, and the difference between Sulfo-PEG, TMAC-PEG, and Ph-PEG at a 
given Φ was also much larger than k values shown in Figure 2-14b (Figure 2-14d). This was due to the 
overestimation by the Fickian diffusion model, which was accentuated by the larger initial drug release 
for hydrogels with lower crosslinking density. Regardless, the D values further demonstrated the greater 
release rates from Sulfo-PEG hydrogels. Taken together, the insulin release was more heavily influenced 
by the changes in charge density of PEG hydrogels with functional pendant chains, which suggested 
that insulin was better able to interact with the functional groups owing to the smaller size, as compared 
to albumin. 
Trypsin. Trypsin is a well-known serine protease responsible for protein digestion in many mammalian 
species, and also widely used for breaking cell aggregates and detaching cells from culture substrates 
in routine biological experiments. Unlike albumin and insulin, trypsin has the pI value of 10.5, thus 
possessing positive charge at physiological pH. Therefore, trypsin encapsulated in Sulfo-PEG hydrogels 
was expected to show lower release rates than TMAC-PEG hydrogels (Figure 2-15a). 
The concentration of PEGMA was first kept at 4% (w/v) (PEGDA concentration of 8% (w/v)). 
The k and D values indicate that the trypsin release from Sulfo-PEG hydrogels was significantly 
reduced at all Φ, compared to albumin and insulin, demonstrating the increased negative charge density 
of Sulfo-PEG hydrogels was able to decrease the release rate of positively-charged trypsin (Figure 
2-15b,e and f). However, the release rates of trypsin from TMAC-PEG hydrogels was not 
significantly enhanced by the increased positive charge via electrostatic repulsion as predicted (Figure 
2-15c and e). This result suggests the positive charge density conferred by TMAC groups was not 
strong enough to exert enough repulsive force to facilitate the release of trypsin, which was in part 
evidenced by the lower absolute zeta potential value of TMAC (0.11 mV) compared to Sulfo group 
(0.21 mV). The exponents, like albumin, were not significantly affected by the type of pendant chains 





Figure 2-15. (a) Protein with pI higher than 7.4 becomes positively charged, and thus expected to have 
a greater release rate in TMAC-PEG hydrogels via repulsion than Sulfo-PEG hydrogels. The release 
profiles of trypsin from (b) Sulfo-PEG hydrogels, (c) TMAC-PEG hydrogels and (d) Ph-PEG hydrogels. 
(e) The kinetic rate constants (k) and (f) exponents (n) were values obtained by fitting the curves with 
Eq. 2-1. (g) Diffusion coefficient (D) were obtained by fitting the curves with Eq. 2-2. The PEGDA and 
PEGMA concentrations of the hydrogels were 8% and 4%, respectively. 
23 
 
Similarly, for the hydrogels at other PEGMA concentrations, the k and D values of trypsin in Sulfo-
PEG hydrogels were significantly reduced as compared to albumin and insulin, whereas those in 
TMAC-PEG hydrogels did not significantly change with Φ (Figure 2-16). The k values in Ph-PEG 
hydrogels, regardless of the crosslinking density of the hydrogels, were also not substantially affected 
by Φ. It is possible that the range of physical properties tuned by the TMAC-PEG hydrogels and Ph-
PEG hydrogels used in this study were not enough to significantly influence the release rate of trypsin. 
 
Figure 2-16. (a,b) Kinetic rate constants (k) and (c,d) diffusion coefficients (D) of trypsin release from 
Sulfo-PEG, TMAC-PEG and Ph-PEG hydrogels, obtained by fitting the release profiles with Eq. 2-1 
and Eq. 2-2, respectively. (a) 10% PEGDA and 2% PEGMA, (b) 6% PEGDA and 6% PEGMA. 
 
2.4 Conclusion 
In this study, various physical properties (i.e. charge density and hydrophobicity) of PEG hydrogels 
were controlled independent of the crosslinking density by presenting pendant PEG chains with 
characteristic end functional groups in order to control the release of proteins having different 
isoelectric points (pI). The PEG hydrogels were fabricated by crosslinking PEGDA with PEGMA 
which becomes pendant PEG chains. While keeping the PEGDA and PEGMA concentrations, the ratio 
of non-functional PEGMA and heterobifunctional PEGMA was varied to control the physical 
properties of the hydrogels without changing the crosslinking density nor the number of total pendant 
chains. Therefore, only the change in physical properties were expected to significantly influence the 
changes in protein release rates. Here, the heterobifunctional PEGMA with sulfonate (‘Sulfo-PEG’), 
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trimethylammonium chloride (‘TMAC-PEG’), and phenyl group (‘Ph-PEG’) were synthesized to 
confer negative charge, positive charge, and hydrophobicity, respectively. The releases of albumin and 
insulin, whose pI values are lower than physiological pH, negatively charged, are more facilitated in 
Sulfo-PEG hydrogels due to electrostatic repulsion as compared to TMAC-PEG hydrogels capable of 
providing attractive force. In addition, the effect of charge type and density was more noticeable for 
insulin, likely due to its smaller size than albumin allowing more interactions with the functional groups. 
On the other hand, the release of trypsin, having positive charge due to higher pI value than 
physiological pH, was significantly diminished in Sulfo-PEG hydrogels via repulsive force. These 
results demonstrate that the PEG hydrogels with pendant functional groups could be successfully 
utilized as vehicles for refined control of protein release for biomedical applications. 
 
Reprinted (adapted) with permission from (M. Kim, and C. Cha, Scientific reports, 2018, 8(1), 1-12). 




CHAPTER 3. Integrative control of mechanical and degradation 
properties of in situ crosslinkable polyamine-based hydrogels for 
dual-mode drug release kinetics 
 
3.1 Introduction 
Hydrogels are extensively investigated in biomedical applications, most notably as drug delivery 
systems and tissue engineering scaffold materials. [15, 49] Their unique blend of physical properties, 
such as hydrophilicity, elasticity and permeability, is ideally suited for those purposes. In addition, these 
properties could be controlled in an efficient manner by varying the crosslinking density of the 
polymeric network or hybridizing with another reinforcing materials (e.g. nanoparticles, 
interpenetrating network). [9, 50, 51] Furthermore, biological activities of cells and tissues incorporated 
within the hydrogel could be modulated by conjugation of cell-responsive moieties (e.g. 
collagen, fibronectin, and laminin). [52, 53] 
The crosslinking reactions to form hydrogels generally involve the use of initiators to start the process. 
For example, radical polymerization with vinyl-based functional groups need radical initiators, such as 
persulfates and phenones. [54-57] However, these reagents often display cytotoxicity, depending on 
their concentrations, so their dosages must be chosen carefully to prevent the cytotoxicity while 
maintaining the ability to start the crosslinking reaction. [58, 59] Therefore, an “in situ” crosslinking 
reaction which occurs under mild conditions and does not involve the use of initiator would be highly 
favored for hydrogel fabrication. [5, 60-64] 
Recently, Michael addition involving amine or thiol as a nucleophilic Michael donor has been 
increasingly adopted to develop in situ crosslinkable hydrogels, because the reaction generally occurs 
at physiologically buffered conditions (i.e. neutral pH, body temperature, ionic strength). [62, 65, 66] 
In addition, amine and thiol are strong enough nucleophiles that often do not require base catalyst for 
initiation. For example, Hubbell and co-workers are one of the first to report the biocompatible reaction 
between 4-arm poly (ethylene glycol) with vinyl sulfone groups as the Michael acceptor 
and cysteine (thiol)-linked oligopeptide as the Michael donor under mild aqueous conditions to 
fabricate hydrogels. [67] 
In this study, in situ crosslinkable hydrogel system between poly (ethylene glycol) diacrylate 
(PEGDA) and polyethyleneimine (PEI) having variable mechanical properties and degradation 
behavior was developed. Both PEGDA and PEI have long been used various biomedical applications 
with proven biocompatibility; PEGDA hydrogels prepared by radical polymerization are commonly 
utilized in drug delivery and tissue engineering, while polycationic PEI has been a popular choice for 
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non-viral gene delivery system via electrostatic nanocomplex formation. [12, 68-70] Herein, however, 
these two polymers were combined to produce in situ crosslinkable hydrogel system by inducing 
Michael addition between two acrylates in PEGDA and multiple amines in PEI. [65, 71] With the 
aforementioned popularity and availability of PEGDA and PEI, this PEGDA-PEI hydrogel system has 
the advantage of cost-effective and efficient production, compared to other types of hydrogels which 
generally require additional chemical conjugation steps to present the functional groups involved with 
the crosslinking reaction. The mechanical properties of PEGDA-PEI hydrogels were controlled by 
changing the crosslinking density through their concentrations and the molecular weight (MW) of 
PEGDA. In addition, the degradation of PEGDA-PEI hydrogels via hydrolysis of the ester linkages, 
under physiological conditions regardless of their mechanical properties, was also explored by 
controlling the degradation rate with PEGDA and PEI concentrations. These degradation and tunable 
mechanical properties of the PEGDA-PEI hydrogels were eventually utilized to control the drug release 
kinetics, in which two different drug release mechanisms occurred in sequence to impart more refined 
overall release profiles. 
 
3.2 Materials and Methods 
3.2.1 Synthesis of poly(ethylene glycol) diacrylate (PEGDA) 
Acrylate was conjugated to PEG by the nucleophilic substitution reaction between hydroxyl end 
groups of PEG and acryloyl chloride. Briefly, poly(ethylene glycol) (PEG, Sigma Aldrich) (MW 1000, 
2000, 3000, and 6000 g mol-1) was first dissolved in dichloromethane at 30 %. 2 molar equivalents of 
acryloyl chloride and triethylamine (Sigma Aldrich) with respect to the hydroxyl groups of PEG were 
added to the mixture and stirred for 24 hours at room temperature with dry N2. After the reaction, the 
insoluble salt formed was filtered out, and the mixture was condensed via rotary evaporation. A large 
excess of diethyl ether was added to precipitate the product. The product was washed three times with 
diethyl ether, and dried under vacuum. The acrylate conjugation was confirmed by 1H-NMR (400MHz, 




Figure 3-1. A representative 1H-NMR spectrum of PEGDA. The peak integration ratio between acrylic 
peaks (a, b, c) and hydroxyethyl peak (d) are listed. 
3.2.2 PEGDA-PEI hydrogel fabrication 
Stock solutions of 40% PEGDA and 20% PEI (MW, 2000 g mol−1, Sigma Aldrich) in phosphate 
buffered saline (PBS, pH 7.4) were mixed in various ratios to prepare a precursor solution. [17, 26, 29]  
The precursor solution was immediately placed in a custom-made mold having 1 mm spacer, and 
incubated at 37 °C until hydrogel was formed. Hydrogel disks (8 mm diameter) were punched out, and 
immersed in PBS until further characterization. 
Rheological characterization was performed to analyze the gelation kinetics of PEGDA-PEI hydrogel 
formation. [72, 73] The PEGDA and PEI solutions were mixed and placed onto a sample holder of a 
rotating-disk rheometer (Kinexus, Malvern), and the changes in storage moduli (G′) and loss 
moduli (G″) were measured during the crosslinking reaction in a small-amplitude oscillatory shear 
mode at 37 °C. During the experiment, the frequency and strain of the rotating disk were 1 Hz and 10%, 
respectively. The gelation time was reported here as the time for the G′ and G″ curves to cross over, 
which represented the point of gelation. 
 
3.2.3 Mechanical properties and degradation of PEGDA-PEI hydrogels 
The rigidity of various PEGDA-PEI hydrogels was measured by calculating their elastic moduli 
obtained from compression experiments. Briefly, the hydrogel disks were subjected to uniaxial 
compression at the rate of 1 mm min−1, and the strain vs. stress curve was obtained (Model 3343, 
Instron). The elastic modulus was determined as the slope of the linear region (first 10%) of the curve. 
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The degradation behavior was analyzed by measuring the change in elastic moduli over time. The 
PEGDA-PEI hydrogels were incubated in PBS at 37 °C, and their moduli were measured at designated 
time points. The degradation rate constants (kd) were obtained by fitting the moduli vs. time curves 
with the following exponential decay model, 
𝐸𝑡
𝐸0
= 𝑒−𝑘𝑑∙𝑡    Eq. 3-1 
where Et was the modulus measured at time, t, and E0 was the initial modulus. [30, 74] 
The homogeneity of PEGDA and PEI after the hydrogel formation was assessed by conjugating a 
fluorophore and monitoring the distribution within the hydrogels. Each PEGDA-PEI hydrogel disk was 
incubated in fluorescein isothiocyanate (FITC, Sigma Aldrich) solution in PBS (0.1 mg mL−1) for 3 h at 
room temperature under dark to induce the reaction between amine and FITC. The conjugation was 
confirmed by the presence of fluorescent color remaining within the hydrogel after extensive washing. 
The FITC-linked hydrogel was visualized with a fluorescence microscope (XDS-3FL, Optika) to assess 
the distribution of fluorophores within the hydrogel. The degradation of FITC-linked hydrogel was 
monitored under the same condition as stated above, and compared with the unmodified hydrogels. 
 
3.2.4 Drug release profiles from PEGDA-PEI hydrogels 
Drug release from various PEGDA-PEI hydrogels was measured to evaluate the effect of mechanical 
properties and degradation behavior. [29, 75] Bovine serum albumin (3 mg mL−1) as a model protein 
drug was encapsulated into PEGDA-PEI hydrogel by dissolving into the precursor solution prior to 
hydrogel fabrication. The hydrogel was incubated in PBS at 37 °C, and the released amount was 
measured at various time points (BCA™ Protein Assay, Thermo Fisher). The cumulative drug release 
profile was fitted to the following two models, 
𝑀𝑡
𝑀∞
= 𝑘1 ∙ 𝑡
𝑛
    Eq. 3-2 
𝑀𝑡
𝑀∞
= 𝑒𝑘2∙𝑡     Eq. 3-3 
where Mt is the released amount at time, t, M∞ is the total amount in the hydrogel, k1 and k2 are the 
kinetic rate constants, and n is the exponents related to the release mechanism. [75-77] Eq. 3-2, a 
power-law release model with fractional time dependence (‘Ritger-Peppas model’) was used to fit the 
initial part of the drug release, while Eq. 3-3, an exponential release model, was used to fit the 




3.3 Results and Discussion 
3.3.1 Mechanical properties of PEGDA-PEI hydrogels 
PEGDA-PEI hydrogels were fabricated by mixing the stock solutions of PEGDA and PEI at various 
ratios to control their mechanical properties Figure 3-2). The concentration of PEGDA was controlled 
at either 10 or 20%, while varying the molecular weight (MW) of PEGDA from 400 (‘PEGDA400’) to 
6000 (‘PEGDA6K’) g mol−1. The PEI concentration was also controlled from 3 to 10%. The lower end 
of this range was chosen as the lowest concentration of PEI resulting in hydrogel formation, while the 
higher end was chosen at which the mechanical properties began to decrease as well as for the 
manageable viscosity (i.e. the viscosity of PEI becomes too high beyond 10%, Figure 3-3). 
 
Figure 3-2. Schematic representation of in situ crosslinkable PEGDA-PEI hydrogels prepared under 
physiological condition. The reaction parameters include the concentrations of PEGDA and PEI as well 
as MW of PEGDA. 
 
Figure 3-3. The viscosity of PEI at various concentrations, measured at room temperature (RT) or 37 °C. 
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The homogeneity of PEGDA-PEI hydrogel was assessed by microscopic imaging of fluorophores 
distributed within the hydrogel. The hydrogel was chemically conjugated with a fluorescent probe (e.g. 
FITC) via unreacted amine groups of PEI. The consistent fluorescent signals throughout the hydrogel 
structure indicate that the PEGDA and PEI were homogeneously mixed and distributed within the 
network (Figure 3-4). 
 
Figure 3-4. (a) Photographic (top) and fluorescent microscopic (bottom) images of PEGDA-PEI 
hydrogels (scale bar: 100 μm). (A: 10 % PEGDA-5% PEI, B: 20 % PEGDA-5% PEI, C: 10 % PEGDA-
3% PEI, D: 20 % PEGDA-3% PEI). (b) (Top) Photographs of PEGDA-PEI hydrogels conjugated with 
(E) or without (F) FITC after incubation in PBS. Greater swelling was observed for F due to accelerated 
degradation. (Bottom) After continuous swelling, F disintegrated while E remained intact. 
3.3.2 Gelation kinetics 
The effects of MW and concentration of PEGDA and the concentration of PEI on the rate of 
crosslinking reaction between PEGDA and PEI were evaluated by measuring the changes in 
viscoelastic properties of the mixture, storage moduli (G′, elastic component) and loss moduli (G″, 
viscous component), over time during the reaction. [72, 73] The rheological characterization was 
performed at the same strain (10%) and cyclic frequency (1 Hz) for all samples. The gelation time was 
determined as the time for G′ to cross over G’’ (‘gel point’), which signified the dramatic increase in 
elastic component by the crosslinking reaction. First, the concentration of PEGDA and PEI were kept 
at 10% and 5%, respectively while controlling the MW of PEGDA (Figure 3-5). The gel point was 
observed up to PEGDA2K (Figure 3-5a-d). However, further increase in MW of PEGDA (PEGDA3K 
and PEGDA6K) did not result in G′ crossing over G″ at any point during the reaction, showing the 
gelation did not occur likely due to the number of acrylic groups below the critical number required 
for gelation under the given concentrations of PEGDA and PEI (Figure 3-6). Increasing the PEGDA 
concentration to 20% while maintaining 5% PEI, the gelation occurred at all MW of PEGDA, on 




Figure 3-5. Rheological properties of the reaction mixture of 10% PEGDA and 5% PEI, evaluated by 
the changes in storage (G′) and loss (G″) moduli measured over time: (a) PEGDA400, (b) PEGDA700, 
(c) PEGDA1K, and (d) PEGDA2K. The arrows indicate the gel point. (e) The gelation times (tgel) of 
10% PEGDA or 20% PEGDA with 5% PEI. (f) tgel values of 20% PEGDA700 with varying 
concentration of PEI. 
 
Figure 3-6. Rheological properties of the reaction mixture of 10 % PEGDA and 5 % PEI, evaluated by 





Figure 3-7. Rheological properties of the reaction mixture of 20 % PEGDA and 5 % PEI, evaluated by 
the changes in storage (G’) and loss (G’’) moduli measured over time: (a) PEGDA400, (b) PEGDA700, 
(c) PEGDA1K, (d) PEGDA2K, (e) PEGDA3K, and (f) PEGDA6K. The arrows indicate the gel point. 
Interestingly, there was a gradual decrease in gelation time (tgel) with increasing MW of PEGDA for 
both 10% and 20% PEGDA (Figure 3-5e, Figure 3-7). In addition, the rate of decrease in tgel with MW of 
PEGDA was much greater at 20%. This result may be deemed counterintuitive in terms of the 
concentration effect on reaction kinetics, in which the higher number of acrylates in lower MW of 
PEGDA at a given concentration is expected to result in greater reaction rate. This interesting result 
may have been due to the increased level of hydrophobicity of PEGDA with lower MW due to the 
higher number of acrylic groups relative to the hydrophilic ethylene oxide chain, preventing more 
stable and homogeneous mixing between PEGDA and PEI. [78] As a result, PEGDA with higher 
MW having greater hydrophilicity may have had favorable interaction with PEI, driving the initial 
crosslinking process. 
The effect of PEI concentration on tgel was also explored by varying the PEI concentration from 3 to 
10% (w/v) reacting with 20% PEGDA700 (Figure 3-5f, Figure 3-8). The tgel values decreased with 
increasing PEI concentration, which was also against the concentration effect since the number of 
amine groups available for crosslinking obviously increase with concentration. Since PEI is known to 
be highly hydrophilic, increased viscosity of PEI at higher concentration likely had the retardation 




Figure 3-8. Rheological properties of the reaction mixture of 20 % PEGDA700 with (a) 3 % PEI, (b) 
5 % PEI, and (c) 10 % PEI. The changes in storage (G’) and loss (G’’) moduli were measured over time. 
The arrows indicate the gel point. 
3.3.3 Rigidity 
The trend in gelation kinetics as discussed above may not necessarily correlate with the mechanical 
properties of the fully-crosslinked hydrogels. With enough time for the completion of crosslinking 
reaction, it could be reasonably inferred that the hydrogels crosslinked with more reactive functional 
groups (e.g. higher concentration and lower MW of PEGDA, and higher concentration of PEI) would 
result in greater rigidity. Therefore, the rigidity of PEGDA-PEI hydrogels was also assessed by 
measuring the elastic moduli from uniaxial compression experiments. First, the concentration of PEI 
was fixed at 5%, while the concentration of PEGDA was controlled at 10% or 20% (Figure 3-9a). The 
moduli did indeed decrease with MW of PEGDA, from PEGDA700 to PEGDA2K for 10% PEGDA, 
and from PEGDA700 to PEGDA6K for 20% PEGDA. However, the modulus of PEGDA400-PEI 
hydrogel was in fact significantly lower than that of PEGDA700-PEI hydrogel. This result may have 
been due to the greater hydrophobicity imparted by the high number of acrylic groups of PEGDA400 
compared to PEGDA700, in which increased hydrophobicity of PEGDA400 may have prevented 





Figure 3-9. Elastic moduli (E) of PEGDA-PEI hydrogels: (a) 10% or 20% PEGDA with 5% PEI at 
varying MW of PEGDA, (b,c) 10% PEGDA or 20% PEGDA with varying PEI concentration and MW of 
PEGDA. (d) The ratio of the number densities of acrylate in PEGDA and amine in PEI (ФAc/Am) for 
varying MW of PEGDA at different PEI concentrations. 
Since the crosslinking reaction occurs via stoichiometric reaction between acrylate and amine, greater 
crosslinking density would be achieved with the stoichiometric ratio close to unity under a given 
polymer concentration. To assess the effect of the stoichiometry of acrylate and amine on the 
mechanical properties of the PEGDA-PEI hydrogels, theoretical number density ratios of acrylate to 
amine (ФAc/Am) were calculated (Figure 3-9d, Table 3-1). As expected, ФAc/Am decreases with MW of 
PEGDA at a given PEGDA concentration, thus the hydrogel rigidity decreased with a result of deviation 
from the stoichiometric unity and reduced crosslinking density. At 20% PEGDA400 in which the 
number of acrylate at the same concentration was the highest, the highest rigidity was shown for 5% 
PEI likely due to the ФAc/Am close to unity (0.86) than other conditions (e.g. ФAc/Am = 0.43 for 3% PEI, 




Table 3-1. The number densities (mol mL-1) of (a) acrylate in PEGDA and (b) amine in PEI at different 
concentrations. 
Next, the effect of PEI content on the rigidity was explored by varying the PEI concentration from 3 
to 10%, while keeping the PEGDA concentration (Figure 3-9b and c). As expected, the hydrogels with 
20% PEGDA generally had greater moduli than those with 10% PEGDA at all MW of PEGDA. The 
range of MW of PEGDA resulting in hydrogel formation at a given PEI concentration was also greater 
at 20% PEGDA. For example, at 3% PEI, the highest MW of PEGDA for gelation was PEGDA2K for 
10% PEGDA, while it was PEGDA3K for 20% PEGDA. Similarly, at 10% PEI, the highest MW of 
PEGDA for gelation was PEGDA1K for 10% PEGDA, while it was PEGDA2K for 20% PEGDA. 
The overall trend in moduli with MW of PEGDA was similar to that shown in Figure 3-9a at all PEI 
concentrations regardless of the PEGDA concentrations; the biphasic trend with the increase in moduli 
from PEGDA400 to PEGDA700, followed by the decrease in moduli from PEGDA700 to PEGDA3K. 
As expected, the moduli of hydrogels with 3% PEI was much lower than those with 5% PEI, due to 
lower amine content. However, with the increase in PEI concentration to 10%, the moduli decreased 
significantly for all MW of PEGDA. The number of acrylic groups of PEGDA at the given concentration 
and MW was likely all consumed by the amine groups of PEI at 5% that the further increase in PEI 
concentration resulted in significant stoichiometric excess of PEI molecules, leading to a limiting effect 
on the crosslinking reaction (i.e. the presence of excess reactants acted as a hindrance). This also helps 
explain the fact that the highest MW of PEGDA for gelation was higher for 3% PEI (PEGDA3K) than 
10% PEI (PEGDA2K), even though the moduli of hydrogels with 10% PEI were generally larger than 
those with 3% PEI; that is, a critically large excess of PEI at 10% PEI at the lowest number of acrylate 
at 10% PEI prevented hydrogel formation by limiting the crosslinking reaction. 
The rigidity of the hydrogels was also evaluated by the G′ values under cyclic shear condition after 
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complete gelation as shown in Figure 3-5 and Figure 3-6 to Figure 3-8 (Figure 3-10). For the hydrogels 
with 10% PEGDA and 5% PEI, the trend in G′ was similar to that of elastic moduli (Figure 3-10a). 
However, when the PEGDA concentration was increased to 20%, G′ values continuously increased 
with MW of PEGDA up to PEGDA2K. Since the hydrogels crosslinked with higher MW PEGDA were 
more resilient, though lower in rigidity, they were able to maintain their structural integrity under shear 
conditions. On the other hand, the hydrogels crosslinked with lower MW PEGDA had much higher 
elastic moduli, but were also much more brittle. Thus, there was extensive fracture occurred for these 
hydrogels during the cyclic shear measurements, resulting in diminished G′ values. Similar results were 
shown for the hydrogels with varying PEI concentrations while maintaining the concentration and 
MW of PEGDA (Figure 3-10b). With 10% PEGDA700, the trend in G′ was similar to that of elastic 
moduli shown in Figure 3-9b. However, with 20% PEGDA700, the G′ at 5% PEI was lower than 3% 
and 10% PEI even though the elastic modulus was higher than the other conditions, which was also 
attributed to the significant brittleness. 
 
Figure 3-10. Storage moduli (G′) of PEGDA-PEI hydrogels, taken from the highest G′ values 
after gelation from the rheological experiments. (a) 10% or 20% PEGDA with 5% PEI at varying MW of 
PEGDA and (b) 20% PEGDA700 with varying PEI concentration. 
3.3.4 Degradation of PEGDA-PEI hydrogels 
It was expected that there would remain a considerable number of unreacted amine groups in the 
PEGDA-PEI hydrogels since it is unlikely that all the amines in a PEI chain would react with the 
acrylate in PEGDA; due to the decreasing conformational and translational mobility of polymer 
chain as the crosslinking reaction proceeds, leading to diminished reactivity. [79] With the PEGDA-
PEI hydrogels linked via ester bonds, the unreacted amine groups would facilitate the hydrogel 
degradation via direct nucleophilic attack or the hydrolysis stemming from the increased hydroxide 
content with the protonation of amine groups (Figure 3-11a). Similar degradation behavior of hydrogels 




Figure 3-11. (a) Degradation mechanism of PEGDA-PEI hydrogels; hydrolysis of ester bonds by 
increased local hydroxide ions and/or direct nucleophilic attack on ester bonds by 
unreacted amine groups. (b) The change in normalized elastic moduli (E/E0) of 10% PEGDA-5% PEI 
hydrogels with varying MW of PEGDA plotted over time. (c) The degradation rate constants (kd) 
obtained by fitting (b) with Eq. 3-1. The kd values for (d) 10% PEGDA and (e) 20% PEGDA linked 
with varying concentrations of PEI. 
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To demonstrate their degradation behavior, the hydrogels were immersed in a physiological buffer 
(i.e. PBS) and the changes in elastic moduli were evaluated over time. As predicted, the PEGDA-PEI 
hydrogels at all conditions demonstrated complete structural disintegration, though at varying rates. 
The fractional change in moduli (E/E0) vs. time (t) profiles were then fitted to an exponential decay 
model (Eq. 3-1) to obtain the degradation rate constant (kd). First, the concentration of PEI was fixed 
at 5% while changing the MW and concentration of PEGDA (Figure 3-11b and c, Figure 3-12). For both 
10% and 20% PEGDA, the degradation rate was significantly influenced by the MW of PEGDA, 
with kd values generally increasing with MW of PEGDA. This result indicated that the hydrogels with 
lower degree of crosslinking showed faster degradation, which was expected since there are less ester 
linkages in the hydrogels need to be broken for degradation and larger osmotic pressure within the 
hydrogels having higher degree of swelling at higher MW of PEGDA. 
 
Figure 3-12. The change in normalized elastic moduli (E/E0) of 20 % PEGDA-5 % PEI hydrogels with 
varying MW of PEGDA plotted over time. The plots were fitted with Eq. 3-1 to obtain the degradation 
rate constants (kd) which are shown in Figure 3-11. 
The degradation was also monitored for the PEGDA-PEI hydrogels with varying PEI concentration 
(Figure 3-11d and e). Generally, the kd values increased with MW of PEGDA regardless of the PEI 
concentration for both 10% and 20% PEGDA, highlighting the dominant effect of the number of 
hydrolysable ester groups. Interestingly, for the highest MW PEGDA (i.e. 10% PEGDA2K and 20% 
PEGDA3K), the kd value was markedly higher at 5% PEI than 3% PEI, even though the modulus was 
much higher at 5% PEI. In addition, the change in kd with MW of 10% PEGDA with 3% PEI was 
significantly lower than those with 5% PEI (Figure 3-11d). Similarly, at 20% PEGDA, the increase 
in kd with MW of PEGDA became more prominent with the concentration of PEI (Figure 3-11e). Taken 
together, it could be concluded that the greater amount of unreacted amine groups at higher 
concentration of PEI likely facilitated the degradation process, irrespective of the difference in the 
initial rigidity of the hydrogels. 
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In situ crosslinkable PEGDA-PEI hydrogels developed in this study undergo degradation via 
hydrolysis of ester groups. If a potential application requires in situ crosslinkable hydrogel to be non-
degradable, one could utilize a different conjugation chemistry which does not result in hydrolysis. For 
example, PEGDA crosslinked in situ with a thiol-based crosslinker (e.g. Thiocure®) to form hydrogels 
did not show any meaningful degradation for several months. [80] Alternatively, PEG with aldehyde 
end groups was crosslinked with a multi-amine polymer, poly (vinyl amine), via Schiff base formation, 
which only showed accelerated degradation at acidic conditions. [81] In addition, “click” chemistry, an 
orthogonal reaction between azide and alkyne functional groups has been utilized to develop in situ 
crosslinkable hydrogels. [63, 82] 
The effect of unreacted amine groups on the degradation via hydrolysis was further confirmed by 
eliminating the amine groups in the hydrogel by chemical reaction. The unreacted amine groups in 
PEGDA-PEI hydrogels were conjugated with FITC, as stated above. These hydrogels were expected 
to remain stable in a physiological condition since the free amine groups were all consumed, as 
compared with unmodified hydrogels which were all shown to undergo degradation. As expected, the 
FITC-linked hydrogels remained stable in PBS while the unmodified hydrogel became fully 
disintegrated, which demonstrated that the unreacted amine groups in the PEGDA-PEI hydrogels were 
responsible for the hydrogel degradation (Figure 3-4). 
 
3.3.5 Degradation of PEGDA-PEI hydrogels 
Tunable mechanical properties, combined with the degradation behavior, of in situ crosslinkable 
PEGDA-PEI hydrogels could be an ideal form of injectable delivery applications. Therefore, the release 
of BSA as a model drug from PEGDA-PEI hydrogels was measured over time and the cumulative drug 
release vs. time (t) profiles were obtained and analyzed (Figure 3-13, Figure 3-14). The overall release 
profiles of PEGDA-PEI hydrogels at all MW of PEGDA interestingly consisted of two different phases 
occurring in sequence: (1) initial power law curve with fractional time dependence (∼tn, 0 < n < 1), 
followed by (2) an exponential curve which showed the rapid rise in release rate before reaching the 
endpoint (Figure 3-13a, Figure 3-14a). This result signified that the initial drug release was governed 
by the swelling behavior of the hydrogels, which stems from the combination Fickian diffusion and 
chain relaxation of the polymeric network, while the later drug release was further facilitated by the 




Figure 3-13. (A) The drug release profiles of PEGDA-PEI hydrogels (10% PEGDA with 5% PEI). The 
profiles consisted of two separate modes of release occurring in sequence; initial swelling-controlled 
mechanism, followed by degradation-controlled mechanism. (b) The initial drug release profiles were 
fitted with Eq. 3-2 and (c) the kinetic rate constants (k1) were obtained. (d) The latter drug release 




Figure 3-14. (a) The drug release profiles of PEGDA-PEI hydrogels (20 % PEGDA, 5 % PEI). The 
profiles consisted of two separate modes of release occurring in sequence; initial swelling-controlled 
mechanism, followed by degradation-controlled mechanism. (b) The initial drug release profiles were 
fitted with Eq. 3-2, and (c) the latter drug release profiles were fitted with Eq. 3-3. The k1 and k2 values 
obtained from (b) and (c) are shown in Figure 3-13. 
The drug release profiles for the first 12 h were first fitted with Ritger-Peppas model (Eq. 3-2) (Figure 
3-13b and c, Figure 3-14b). As expected, the kinetic rate constants (k1) values increased with MW of 
PEGDA, from PEGDA700 to PEGDA3K for 20% PEGDA and from PEGDA700 to PEGDA2K for 
10% PEGDA, since the release is generally faster from hydrogels with less crosslinking density. The 
release rate from PEGDA400-PEI hydrogel was surprisingly much higher than any other condition 
despite having the highest crosslinking density, suggesting the highly elevated hydrophobicity at the 
lowest MW PEGDA (i.e. aforementioned high acrylate/ethylene oxide ratio in lower MW PEGDA) had 
driven the hydrophilic molecules out of the hydrogels more readily than other conditions. 
The subsequent drug release profiles which showed a rapid increase in release rates were then fitted 
with an exponential drug release model (Eq. 3-3) to account for the drug release governed by the 
hydrogel degradation and obtain the kinetic release rate constants (k2) (Figure 3-13d–e, Figure 3-14c). 
Similar to the trend for degradation kinetics (kd) in Figure 3-11, the k2 values increased with MW of 
PEGDA for both 10% and 20% PEGDA, thus confirming that the release kinetics following the initial 
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swelling-controlled mechanism were largely governed by the hydrogel degradation. 
This sequential drug release profiles were also demonstrated in the hydrogels crosslinked by varying 
PEI concentrations for both 10% and 20% PEGDA (Figure 3-15). The trends k1 values for both 10% 
and 20% PEGDA were generally inversely related to the mechanical strength of the hydrogels as shown 
in Figure 3-9, as expected, indicating the initial drug release was mostly governed by the hydrogel 
diffusion (Figure 3-15a and c). The increase in k2 values with MW of PEGDA was more prominent at 
higher PEI concentrations, pointing to the effect of higher degradation rate at higher PEI concentration 
on the accelerated drug release (Figure 3-15b and d). Especially, the k2 value for 10% PEGDA1K-10% 
PEI was significantly higher than any other condition, which likely stemmed from the combination of 
weak mechanical strength, as identified by the low elastic modulus shown in Figure 3-9, and the high 
content of unreacted amine groups facilitating the hydrogel degradation (Figure 3-15b). At lower PEI 
concentrations, the trend in k2 values with MW of PEGDA at 10% followed more closely to that of their 
mechanical strength, suggesting greater influence of diffusion than degradation on the drug release. 
Interestingly at 20% PEGDA, the dependence of k2 values on the hydrogel degradation was more 
evident, as their trends closely followed those of kd values in Figure 3-13 (Figure 3-15d). This 
suggested that for hydrogels with higher crosslinking density having greater mechanical strength and 
lower diffusion, the effect of degradation on the drug release was much more significant than that of 
diffusion. These results clearly highlighted that this dual-mode drug release behavior is a unique 
characteristic of this PEGDA-PEI hydrogel system regardless of the reaction conditions. 
 
Figure 3-15. k1 and k2 values obtained from drug release profiles of PEGDA-PEI hydrogels. (a,b) 10% 




Figure 3-16. The drug release profiles of PEGDA-PEI hydrogels. (a) 10 % PEGDA with 3 % PEI, (b) 
10 % PEGDA with 10 % PEI, (c) 20 % PEGDA with 3% PEI, (d) 20 % PEGDA with 10% PEI. 
 
3.4 Conclusion 
In this study, mechanical properties and degradation behavior of PEGDA-PEI hydrogels prepared by 
in situ crosslinking between PEGDA and PEI via Michael addition were explored. The abundance of 
free amine groups in PEI, as well as tunable number of acrylic groups of PEGDA via variable MW and 
concentration, allowed for facile crosslinking reaction to form hydrogels under mild, physiological 
conditions without the need of a catalyst. Mechanical properties of the PEGDA-PEI hydrogels could 
be controlled in a wide range by varying the concentrations of PEGDA and PEI, as well as the MW of 
PEGDA. Interestingly, the hydrogels all underwent complete degradation, likely due to the unreacted 
amine groups responsible for the hydrolysis via local basic environment or the direct nucleophilic 
attack on the ester linkages. This combination of tunable mechanical properties and degradation 
behavior of the PEGDA-PEI hydrogels was highly effective in modulating the rate and mode of drug 
release by sequential swelling- and degradation-controlled mechanisms. Taken together, this in situ 
crosslinkable hydrogel system with tunable physical properties as well as injectability is expected 
provide an efficient and effective platform for biomedical applications. 
 
Reprinted (adapted) with permission from (M. Kim, and C. Cha, Polymer, 2018, 145, 272-280). 
Copyright (2018) Elsevier. https://doi.org/10.1016/j.polymer.2018.05.020 
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CHAPTER 4. In situ facile-forming chitosan hydrogels with 
tunable physicomechanical and tissue adhesive properties by 
polymer graft architecture 
 
4.1 Introduction 
Hydrogels have become an indispensable part of biomedical engineering, as carriers of biologically-
relevant therapeutic molecules (e.g. drugs, proteins, DNA) for drug delivery and artificial extracellular 
matrices (ECM) for tissue engineering. [15, 49, 83] With increasing awareness of importance of cellular 
microenvironment, hydrogels are growingly utilized as cell-culture platform for fundamental biological 
investigation. [84-86] In addition, the hydrogels are increasingly translated into commercial products 
in personal care and medical markets, such as wound dressing, adhesives, and cosmetics. [2] Hydrogels, 
unlike other types of materials commonly used in biomedical applications such as nanofibers and 
elastomers, possess a unique blend of controllable elasticity and hydrophilicity (i.e. high water content) 
that allow for broad applicability. 
Most hydrogels are generated by employing chemical reactions to crosslink hydrophilic monomers or 
macromers. For example, radical polymerization is commonly adopted for unsaturated compounds for 
fast reaction rate and wide range of materials; in addition to small molecules, such as acrylamide, 
acrylic acid, methyl methacrylate, and 2-hydroxyethyl methacrylate, macromers devoid of radically 
active functional groups can be easily rendered as such by simple chemical reactions, such as 
poly(ethylene glycol) diacrylate, methacrylate-conjugated gelatin and alginate. [54, 87] The radical 
polymerization requires the use of initiators, which often becomes problematic for bioencapsulation 
due to possible toxicity. Even for those deemed biocompatible (e.g. Irgacure2959, lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (‘Li-TPO’), and 2,2'-azobis[2-methyl-N-(2-hydroxyethyl)propionamide] 
(‘VA-086’) [88, 89], it is still difficult to keep the initiator concentration low enough to maintain the 
biocompatibility while allowing enough chemical reactions to form hydrogels. 
The hydrogels formed by spontaneous chemical reaction between two macromers have gained 
significant research interest over the last two decades. Broadly termed as “in situ forming” hydrogels, 
they have the advantage of biocompatible fabrication as they can be formed by mild chemical reactions 
without the use of cytotoxic initiators under physiologically-relevant conditions (e.g. ambient 
temperature, neutral pH. [5, 90, 91] For example, Hubbell and co-workers were one of the first to report 
the hydrogel fabrication under mild conditions via Michael addition reaction between thiol and vinyl 
groups and biocompatible cell encapsulation. [67, 92] Schiff base, an imine linkage formed by the 
addition between amine and carbonyl groups followed by dehydration, similarly has been utilized to 
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generate hydrogels. [93-96] Due to this mode of hydrogel fabrication, the in situ forming hydrogels 
have been considered especially attractive as a tissue injectable and implantable form for biomedical 
applications, allowing spontaneous hydrogel formation upon delivery. [91, 97-99] 
One of the major challenges of in situ forming hydrogel is the control of mechanical properties in a 
wide range while appropriately maintaining the rate of crosslinking reaction, at least within a 
manageable range for practical handling. Since the mechanical properties are governed by the 
crosslinking density which also controls the rate of gelation (i.e. the hydrogel forms faster at higher 
crosslinking density, and slower at lower crosslinking density). As a result, the hydrogel with low 
mechanical strength may be too slow to form, while it may form too fast to allow handling and 
processing for the hydrogel with greater mechanical strength. For radical polymerization, on the other 
hand, the rate of hydrogel formation is largely determined at initiation and can be effectively controlled 
by the initiation parameters, such as initiator concentration and degree of activation (e.g. heat, light, 
and amount of co-initiator). [16, 100] 
In this study, physical properties of gel-forming polymer were varied to control the mechanical 
properties of in situ forming hydrogels, while effectively maintaining the gelation kinetics. Chitosan 
was chosen as the gel-forming polymer, widely used in biomedical applications for its innate anti-
microbial properties as well as biocompatibility and abundant natural source. [96, 101-104] More 
significantly, an extensive number of amine groups on chitosan, one on each saccharide monomer, 
provides ample avenue for chemical modifications, including various nucleophilic reactions for in situ 
forming hydrogels. Here, hydrophilic poly(ethylene glycol) (PEG) chains were conjugated onto the 
chitosan backbone with varying graft length and density (‘PEG-g-Cs’), and their effect on the 
mechanical properties of the resulting hydrogels crosslinked via Schiff base formation were evaluated 
(Figure 4-1). The chitosan with PEG graft architecture not only served to control the physicomechanical 
properties of hydrogels, it also allowed the chitosan to be readily dissolved in neutral aqueous solutions, 
by removing some of the amine groups in chitosan (i.e. native polycationic chitosan only dissolves in 
acidic conditions). [105, 106] In addition, the physical dimension (i.e. chain length) of the crosslinker, 
PEG-dialdehyde, was also varied to further control the gel mechanics by modulating the interaction 
with polymer grafts. To further illustrate their potential application as tissue sealant, the adhesive 
properties of the in situ forming Cs-PEG hydrogels on biological tissues were examined both ex vivo 




Figure 4-1. (a) PEG grafting of chitosan (PEG-g-Cs). mPEG was first oxidized to present aldehyde 
groups (mPEG-aldehyde), which was then reacted with chitosan via Schiff base formation. Sodium 
cyanoborohydride was used to irreversibly reduce the Schiff base into secondary amine. (b) Schematic 
representation of in situ forming PEG-g-Cs hydrogel, with PEG-dialdehyde (PEGDAld) as a crosslinker. 
(c) FT-IR spectra of PEG750-g-Cs (a: vs(C-H), b: vs(C-O-O)(anti) (carboxylic acid salt), c: vs(C-
N), d: vs(C-O-C)(anti)). (d) DSC curves of PEG750(0.7)-g-Cs and PEG2K(0.7)-g-Cs. (e) The microbial 
inhibition rates of PEG750(1)-g-Cs and PEG750(1)-g-Cs. 
 
4.2 Materials and Methods 
4.2.1 Synthesis of PEG-grafted chitosan (‘PEG-g-Cs’) and PEG-dialdehyde 
Chitosan conjugated with poly(ethylene glycol) (PEG) with varying lengths and density was 
synthesized by a two-step process: (1) the synthesis of methyl ether PEG (mPEG)-aldehyde and (2) the 
conjugation of mPEG-aldehyde onto the chitosan. [107, 108] 
First, PEG with an aldehyde end group was synthesized by the oxidation of methyl ether PEG (mPEG). 
mPEG (MW of 750 or 2000 g mol-1, mPEG, Sigma Aldrich) was first dissolved in dimethyl sulfoxide 
(DMSO)/chloroform (8:2 volume ratio, Samchun Chemicals, Korea) at 20 wt%. DMSO/chloroform 
was treated with dry molecular sieve (3 Å, Sigma Aldrich) to remove residual water and sonicated for 
30 minutes for degassing. Acetic anhydride (Sigma Aldrich) was added to the mixture and continuously 
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stirred at room temperature for 24 hours under dry N2. The molar ratio of mPEG to acetic anhydride 
was 1:3. The mixture was precipitated and washed twice with excess diethyl ether, and then dried under 
vacuum to obtain mPEG-aldehyde. 
Chitosan was reacted with mPEG-aldehyde via Schiff base reaction to develop PEGylated chitosan 
(PEG-g-Cs). Briefly, 1 g chitosan (Cat#448869, low MW, 75-85 % deacetylation, Sigma Aldrich) was 
dissolved in a mixture of 40 mL acetic acid solution (2 wt%, Samchun Chemicals, Korea) and 20 mL 
methanol (Samchun Chemicals, Korea). mPEG-aldehyde, as synthesize above, was added to the 
mixture and stirred for 30 min. Two different grafting densities (DS) of mPEG on chitosan, defined by 
the feed molar ratio of mPEG-aldehyde to saccharide groups in chitosan, were prepared; 0.7 and 1. 
Then, the pH of the mixture was adjusted to 6 with a slow addition of 1 M NaOH and stirred for 1 hour. 
In this step, ultrasonication was applied (VCX130, Sonic) in a pulse mode (output power: 65 W, 
frequency: 70 kHz, pulse: 30 seconds on, 10 seconds off) until the aggregation disappeared. Sodium 
cyanoborohydride (0.7 molar equivalent of added mPEG-aldehyde, Sigma Aldrich) was added and 
continuously stirred for 24 hours to reduce the Schiff base to irreversible secondary amine. The entire 
process was done at room temperature. The mixture was extensively dialyzed against deionized (DI) 
water and the product was obtained by lyophilization. The PEG grafting density and length were 
evaluated by FT-IR spectroscopy (Cary 670, Agilent), 1H-NMR spectroscopy (400 MHz, Avance III, 
Bruker), and differential scanning calorimetry (Q200, TA Instruments).  
The degree of substitution (DSPEG), defined as the percentage of amine groups substituted with PEG 
grafts, was determined indirectly by measuring the amount of remaining amine groups via 2,4,6-
trinitrobenzenesulphonic acid (TNBS) assay. Briefly, 0.05 mL of PEG-g-Cs sample in DI water and 
0.05 mL of TNBS working solution (0.1 % TNBS, 4 % NaHCO3, pH 8.5) were mixed and incubated 
in 37 °C for 2 hours. Afterwards, 0.05 mL of 10 % sodium dodecyl sulfate and 0.05 mL of 1 M HCl. 
The absorbance at 335 nm (Abs335) was measured using a spectrophotometer (Synergy HTX, BioTek). 










=      Eq. 4-1 
where Abs335(Cs) and Abs335(PEG-g-Cs) were the absorbance values at 335 nm for unmodified 
chitosan and PEG-g-Cs, respectively. The grafting efficiency (GEPEG), defined as the percentage of 
mPEG-aldehyde reacted with chitosan, was calculated as the percentage of experimental DSPEG from 




Table 4-1. DSPEG of various PEG-g-Cs 
PEG-dialdehyde as the crosslinker for PEG-g-Cs was synthesized by acetic anhydride/DMSO 
oxidation of PEG, as similarly done for mPEG-aldehyde. Instead of mPEG, PEG having hydroxyl 
groups on both ends was used. Briefly, PEG was first dissolved in DMSO/chloroform (8:2) at 20 wt%, 
followed by the addition of acetic anhydride. The molar ratio of hydroxyl groups of PEG to acetic 
anhydride was 1:3. The mixture was continuously stirred at room temperature for 24 hours. The product 
was obtained by precipitation in excess diethyl ether. Three different MWs of PEG, 2000, 3400, and 
6000, were used (Sigma Aldrich). 
 
4.2.2 Fabrication of Cs-PEG hydrogels 
Stock solutions of PEG-g-Cs (8 % for PEG750-g-Cs, 10 % for PEG2K-g-Cs) and PEG-dialdehyde 
(60 %) were prepared in DI water. The solutions were thoroughly mixed, placed between two glass 
plates (1 mm spacer), and incubated at 37 °C to allow Cs-PEG hydrogel formation. Hydrogel disks 
(8 mm diameter) were punched out and kept in phosphate buffered saline (PBS, pH 7.4) before 
characterization. The range of concentrations of PEG-g-Cs was 3-8 %, while that of PEG-dialdehyde 
was 5-20 %. At a given PEG-g-Cs concentration, only the MW of PEG-dialdehyde was varied while 
keeping the concentration. For measuring adhesive properties, the stock solutions were placed in 
separate containers of a dual syringe (Nordson EFD), and extruded out of the single outlet of the syringe 
together, and onto a biological tissue sample. The two solutions joined prior to exiting the syringe, and 
the mixture became a clear, homogeneous solution without apparent phase separation, as they passed 
through the narrow outlet. 
 
4.2.3 Mechanical and rheological properties of Cs-PEG hydrogels 
The mechanical properties of Cs-PEG hydrogel were measured by uniaxial compression experiments 
(Model 3343, Instron). [94, 95, 109] Each hydrogel disk was compressed at the rate of 1 mm min-1 and 
a stress-strain curve was obtained. The elastic modulus was calculated as the slope of the stress-strain 
curve at the first 10 % strain. For each condition, the mean and standard deviation values were reported 
(n = 6). 
Gelation kinetics of Cs-PEG hydrogel was evaluated using a rotating-disk rheometer (Kinexus, 
 
Samples DSPEG (%) 
PEG750(0.7)-g-Cs 26.5 ± 0.8 
PEG2K(0.7)-g-Cs 30.7 ± 1.6 
PEG750(1)-g-Cs 35.8 ± 0.7 
PEG2K(1)-g-Cs 36.2 ± 1.2 
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Malvern). [72, 94] The storage moduli (G') and loss moduli (G") of the mixture of PEG-g-Cs and PEG-
dialdehyde solutions were measured over time at 37 °C in a small-amplitude oscillatory shear mode. 
The frequency and strain of the rotating disk were 1 Hz and 10 %, respectively. The gelation time was 
determined by the time at which G' crossed over and exceeded the G". 
 
4.2.4 Diffusional properties of Cs-PEG hydrogels 
The diffusional properties of Cs-PEG hydrogels were evaluated by measuring their swelling ratios and 
drug release profiles. The weight of a fully swollen hydrogel, obtained by incubating in PBS at 37 °C 
for 24 hours, and that of a dried gel mesh, obtained by lyophilization, were measured. The swelling ratio 
was calculated as the weight ratio of swollen hydrogel to dry gel mesh. Drug release characteristic from 
Cs-PEG hydrogels were evaluated using bovine serum albumin (BSA, Sigma Aldrich) as a model 
protein drug. BSA (5 mg mL-1) was encapsulated into Cs-PEG hydrogel by dissolving in the PEG-g-Cs 
stock solution prior to hydrogel fabrication. Each hydrogel disk was incubated in 0.5 mL PBS at 37 °C 
and the BSA released to the medium was analyzed using BCATM Protein Assay kit (Thermo Fisher), 
following the manufacturer’s instructions. The cumulative drug release profile was fitted to the 
following Ritger-Peppas equation, 
𝑀𝑡
𝑀∞
= 𝑘 ∙ 𝑡𝑛    Eq. 4-2 
Mt is the amount of drug released at a time, t, M∞ is the total amount of drug in the hydrogel, k is the 
kinetic rate constant, and n is the exponent related to the release mechanism. [43, 93, 95] 
 
4.2.5 Tissue adhesive properties of Cs-PEG hydrogels 
Ex vivo lap-shear test. The adhesive properties of Cs-PEG hydrogel were measured based on a 
standard method for strength properties of tissue adhesives in lap-shear by tension loading (ASTM 
F2255-05). [103, 110-112] The measurements were performed using porcine skin (purchased from 
Biozoa Biological Supply Co., Korea). The skin specimens (15 × 25 mm each) were first washed by 
immersing in PBS at 37 °C for 1 hour, and each glued to an acrylic fixture using cyanoacrylate glue. 
Afterwards, Cs-PEG mixture (100 μL) was spread on the surface of one skin specimen, immediately 
covered with another specimen, and incubated at 37 °C to allow hydrogel formation. After curing, the 
set-up was loaded onto the universal testing machine (Model 3343, Instron) via the acrylic fixture on 
tensile grips, and then uniaxially elongated at the rate of 10 mm min-1 until the hydrogel broke and the 
two skin specimens separated. 
From the stress-strain curve obtained, several parameters for adhesive properties were obtained. The 
shear modulus was calculated as the slope at the first 10 % strain. The adhesive strength was calculated 
by dividing the maximum load by the bond area. The fracture energy was calculated by dividing the 
50 
 
integral of the force-elongation curve by the adhesion area until the adhesion failed. For each condition, 
the mean and standard deviation values were reported (n = 12). 
 
Ex vivo burst pressure test. The adhesive properties of Cs-PEG hydrogel were alternatively measured 
by applying hydraulic pressure to Cs-PEG hydrogel attached to the porcine skin tissue to measure burst 
pressure, based on an ASTM standard test (ASTM F2392-04). [111, 113, 114] The burst pressure 
experiments were performed using a custom-built device consisting of an electronic pump (Legato100, 
KD Scientific), a pressure gauge (P421 series, Wise Control Inc., Korea), and a cylindrical fluid 
chamber (2 cm diameter, 5 cm height, open top), all connected via plastic tubing. The sample was first 
prepared by applying Cs-PEG mixture (150 u L) to a hole (5 mm diameter) in a porcine skin specimen. 
After gelation, the skin specimen was attached on top of the fluid chamber and firmly fastened with a 
cable tie to prevent fluid leakage. Then, PBS was injected into the fluid chamber via the electronic 
pump at 3 mL min-1 until the adhesive broke and visible fluid leaked. The burst pressure was reported 
as the maximum pressure recorded during the measurement. For each condition, the mean and standard 
deviation values were reported (n = 12). 
 
In vivo skin wound closure test. To investigate the in vivo biocompatibility and skin wound closure 
properties of Cs-PEG hydrogel as tissue sealant, a rat skin incision model was used with the approval 
from Institutional Animal Care and Use Committee (#UNISTIACUC-18-22) of Ulsan National 
Institute of Science and Technology (UNIST). [110, 115] Normal Sprague Dawley (SD) rats (Male, 3 
weeks, 50 g, Hyochang Science, Korea) were anesthetized using isoflurane (liquid for inhalation, 
TerrellTM) and shaved off their backs. 20 mm long incision was made on the rat’s back. Then, 300 μL 
of a tissue sealant was evenly applied along the incised area using a custom-made syringe (0.75 mm 
thickness, 8 mm wide). Untreated and sutured samples were used as control groups. After 1 day to 
allow the incised tissue to close, the hydrogel adhesive was removed. 
The wound recovery process was monitored up to five days with photography and optical coherence 
tomography (OCT) imaging. The detailed specifications of the OCT device used in this study are 
provided in the Supplementary Information. The OCT enabled non-invasive 3D imaging and 
monitoring morphological changes of deep tissue with high resolution. [116, 117] Using this technology, 
the skin tissue down to hypodermal layer surrounding the wound area covered by tissue sealant was 
imaged and analyzed in real-time throughout the experiment. 
On day 3, the animals, one from each condition, were sacrificed and the tissue sections around the 
wound site were harvested for histological evaluation. A standard hematoxylin and eosin (H&E) 
staining was performed on the tissue sections, and visualized with an inverted optical microscope 
(CKX53, Olympus). All the ex vivo and in vivo adhesion tests were performed with a commercially 




4.2.6 Anti-microbial properties of PEG-g-Cs 
The anti-microbial properties of PEG-g-Cs were evaluated by a standard broth dilution method.[118, 
119] Briefly, a small piece of colony of E. coli on agar plate was transferred to a saline solution (0.9 
wt% NaCl) and mixed well with vortexing. McFarland diluent (0.05mL of 0.005 % BaCl2 and 0.995 % 
H2SO4 in DI water) was added until the absorbance at 600 nm becomes 0.25~0.3 (i.e. McFarland 
standard). A sample solution was prepared by mixing 100 μL of PEG-g-Cs solution with 50 μL Mueller-
Hinton Broth medium (MHB, Sigma Aldrich) and 50 μL McFarland standard, and placed in a well of 
a 96-well plate. The plate was incubated at 37 °C with gentle shaking, and the absorbance at 600 nm 
was measured at different times up to 12 hours using a spectrophotometer (Multiskan GO, Thermo 
Fisher). Pure MHB solution (200 μL of MHB) was used as a negative control, and bacteria solution 
(150 μL of MHB and 50μL of McFarland standard) as a positive control. 
Alternatively, the anti-microbial properties of PEG-g-Cs hydrogels were determined. Briefly, 5 % 
PEG-g-Cs and 20 % PEGDAld in LB medium with varying MW were mixed together and placed into 
24-well plates. After Cs-PEG hydrogels were formed, each hydrogel surface was inoculated with 50 
μL of E. coli solution by streaking across the hydrogel surface. After 16 hours of culture at 37 °C, the 
bacterial growth on the hydrogel surface was visualized by staining with MTT solution (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma Aldrich), which turned live bacteria 
brown-purple. A standard LB agar plate was used as a control. 
 
4.2.7 Swept-Source Optical Coherence Tomography (SS-OCT) 
The swept source laser (Axsun Technologies, Inc., US) integrated into the SS-OCT system has 1,310 
nm center wavelength and 110 nm tuning range with a sweep rate of 20 mW and axial resolution of ~ 
8 μm in tissue. The light emitted from the swept source laser moved along the fiber optics based on 
Mach-Zehnder interferometry and it split into sample arm and reference arm following fiber coupler 
and a circulator. The sample arm responsible for imaging of the skin sample was composed of a 
collimator, two-axis galvanometer scanner, and objective lens providing lateral resolution of ~ 15 μm 
in tissue. Reflected light from the sample and reference arm were combined and these interference 
signals converted to an electrical signal by a balanced photodetector (PDB450C, Thorlabs Inc., US). 
The electrical signals digitized by a digitizer (ATS9350, AlazarTech Inc., Canada), and then an 
intensity-based image was generated. The intensity-based 1D arrays called A-line images were 
accumulated using a galvanometer scanner in the sample arm to reconstruct a 2D OCT image which is 
the cross-sectional image of the sample. Also, a 3D OCT image which has volumetric information of 




4.3 Results and Discussion 
4.3.1 Synthesis and physical properties of PEG-g-Cs 
Chitosan is a highly unique cationic polysaccharide biopolymer, obtained by deacetylation of N-
acetylglucosamine units of naturally-occurring chitin to generate a significant amount of secondary 
amine-containing N-glucosamine units. [96, 101, 102, 120] In addition to biocompatibility, this highly 
polycationic nature renders chitosan natural anti-microbial properties (i.e. polycations are known to 
disrupt bacterial cell walls). Hydrogels made from chitosan have been extensively investigated not only 
in biomedical applications such as drug delivery, tissue scaffolds, and wound dressings, but also in 
environmental applications, mostly for removing toxin via adsorption. However, there are several 
issues that need to be addressed for more complete biomedical utilization of chitosan. First, the 
polycationic nature only allows dissolution in acidic aqueous conditions, preventing biocompatible 
encapsulation of biological molecules (e.g. proteins and DNAs) and cells. Second, it is difficult to 
control the mechanical properties of chitosan hydrogels, with high viscosity of chitosan limiting the 
range of concentration. Third, since chitosan hydrogels are commonly fabricated by anionic 
crosslinkers such as glycerophosphate and tripolyphosphate, there is a possibility of losing their long 
term stability with ion leaching. 
To overcome these limitations, in situ forming chitosan hydrogels with varying mechanical properties 
were developed. Chitosan was first conjugated with hydrophilic PEG chains with varying length and 
density, PEG-g-Cs (Figure 4-1a). This PEG-graft architecture of chitosan served two purposes; 
eliminate some of the amine groups and increase the hydrophilicity to allow dissolution in neutral 
aqueous conditions, and control the mechanical properties of resulting hydrogels by modulating the 
physical interaction with crosslinking molecule, PEG-dialehdyde (PEGDAld). In situ forming 
mechanism also has the advantage of biocompatible hydrogel formation without the need for 
potentially toxic initiators, and more scalable mechanics and structural durability over ionic 
crosslinking. 
The length of PEG graft on PEG-g-Cs was controlled; 750 (‘PEG750’) and 2000 (PEG2K) g mol-1, 
while the grafting density was also controlled; 0.7 and 1 feed molar equivalents of saccharide groups 
in chitosan. They are designated as PEG750(0.7)-g-Cs, PEG750(1)-g-Cs, PEG2K(0.7)-g-Cs, and 
PEG2K(1)-g-Cs. The degree of substitution of PEG grafts, experimentally determined via TNBS assay, 
indeed showed greater grafting density for PEG(1)-g-Cs than PEG(0.7)-g-Cs (Table 4-1). Unlike 
unmodified chitosan, PEG-g-Cs also showed very high aqueous solubility at neutral pH, with 
maximum aqueous solubility of 8 % and 10 % for PEG750-g-Cs and PEG2K-g-Cs, compared to 6 % 
for NCE-Cs. This further demonstrated that the hydrophilic PEG grafts could facilitate greater water 
solvation, and longer PEG grafts allowed greater separation between chitosan chains. 
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Spectroscopic and calorimetric characterizations of PEG-g-Cs. The PEGylation was confirmed with 
NMR, FT-IR, and DSC analyses, with N-carboxyethyl chitosan (NCE-Cs), a widely-investigated form 
of substituted chitosan for neutral buffer solubility, serving as a control group. [73, 121, 122] 1H-NMR 
and FT-IR spectra both showed peaks corresponding to PEG grafts for PEG-g-Cs, confirming the 
presence of PEG grafts (Figure 4-1c, Figure 4-2, and Figure 4-3). 
DSC thermograms of PEG750-g-Cs and PEG2K-g-Cs showed characteristic endothermic peaks at 
34 °C and 54 °C, respectively, which corresponded to Tm and ΔH of PEG grafts on chitosan (Figure 
4-1d, Figure 4-4). In addition, ΔH of PEG grafts for PEG2K-g-Cs was much higher than that of 
PEG750-g-Cs. Furthermore, ΔH of PEG grafts increased with graft density, more so for PEG2K-g-Cs. 
These findings demonstrated that the PEG grafts on chitosan allowed their crystallization, and the 
degrees of crystallinity increased with the graft length and density. [123] On the other hand, NCE-Cs, 
devoid of PEG grafts, did not show such melting phenomena at the same temperature. Overall, these 














Figure 4-2. Representative 1H-NMR spectra of (a) N-carboxyethyl chitosan (NCE-Cs) and (b) PEG-g-




Figure 4-3. FT-IR spectra of PEG2K-g-Cs. a: vs(C-H), b: vs(C-O-O)(anti) (carboxylic acid salt), c: vs(C-
N), d: vs(C-O-C)(anti) 
 
Figure 4-4. Representative DSC curves of (a) N-carboxyethyl chitosan (NCE-Cs) and (b) PEG-g-Cs. 







Anti-microbial activity of PEG-g-Cs. One of the hallmarks of chitosan is the natural anti-microbial 
activity, owing to its polycationic nature. Since many of the amine groups were converted to PEG grafts, 
it was plausible that the anti-microbial activity could have been reduced as a result. Therefore, anti-
bacterial activity was evaluated by measuring the viability of E. coli in response to varying 
concentrations of PEG750(1)-g-Cs and PEG750(1)-g-Cs up to 3 % (Figure 4-5) after 12 hours of 
exposure, and the microbial inhibition, defined as the percentage of decrease in microbial growth from 
the positive control (no treatment), was calculated (Figure 4-1e). For PEG750(1)-g-Cs, there was 
almost a complete microbial growth arrest at 2 % and above, and with gradual decrease in anti-
microbial activity with decreasing concentrations. Even at the lowest concentration at 0.1 %, the 
microbial activity was inhibited by 65 %, demonstrating significant anti-microbial effect. For 
PEG2K(1)-g-Cs, on the other hand, the anti-microbial activity was reduced, likely due to the increased 
portion of PEG relative to chitosan. Nonetheless, significant microbial inhibition was demonstrated at 
various concentrations of PEG2K(1)-g-Cs; 70 % inhibition at 3 %, 64 % inhibition at 2 %, and 55 % 
inhibition at 1.5 %. It should be noted that after initial growth inhibition, there is a gradual microbial 
growth over time, likely due to the small amount of remaining bacteria growing in the culture media. 
 
Figure 4-5. Anti-bacterial properties of (a) PEG750(1)-g-Cs and (b) PEG2K(1)-g-Cs at various 
concentrations by measuring the viability of E. coli over time. 
4.3.2 Mechanical properties of Cs-PEG hydrogels 
In order to fabricate hydrogels by in situ chemical reaction, PEGDAld was used as a crosslinker which 
is able to undergo Schiff base reaction with amine groups of PEG-g-Cs. The MW of PEGDAld was 
varied, 2000 (‘2K’), 3400 (‘3.4 K’) and 6000 (‘6K’) g mol-1, to control the mechanical properties of 
the resulting “Cs-PEG” hydrogels by varying the number of reactive functional groups; PEGDAld with 
higher MW would have less reactive functional groups at the same concentration. Furthermore, the 
chain length of the polymeric crosslinker could influence the physical interaction with PEG-g-Cs, 
especially with regards to varying PEG graft length and density. 
First, for a PEG-g-Cs with given concentration and PEG grafting density at 0.7, the MW of the 
PEGDAld was varied while keeping the concentration at 20 % to develop Cs-PEG hydrogels. At 3 % 
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PEG750(0.7)-g-Cs, the elastic modulus (E) was the highest at intermediate MW of PEGDAld 
(PEGDAld3.4 K), and the lowest at low MW PEGDAld2K, suggesting there is an optimal chain length 
for maximal crosslinking reaction (Figure 4-6a). It is especially interesting that the hydrogel 
crosslinked with PEGDAld2K, which had the most reactive functional groups, had the lowest E, which 
further highlighted the importance of proper physical interaction between two polymers. It was possibly 
due to the difficulty of shorter PEGDAld to crosslink PEG-g-Cs chains with steric hindrance by 
surrounding PEG grafts (Figure 4-6e). [124-126] On the other hand, further reduced number of reactive 
groups for high MW PEGDAld also likely caused the decrease in E even with greater accessibility. 
When the concentration was increased to 5 % PEG750(0.7)-g-Cs, E increased at all MW of PEGDAld, 
as expected. But the E increased with the MW of PEGDAld, with the maximum value at PEGDAld6K, 
rather than the intermediate PEGDAld3.4 K. It is speculated that at higher concentration, with greater 
steric hindrance by PEG grafts on chitosan for PEGDAld to overcome, it was more difficult for low 





Figure 4-6. Elastic moduli (E) and swelling ratios (Q) of Cs-PEG hydrogels. (a, c) PEG750-g-Cs, (b, 
d) PEG2K-g-Cs. PEG-g-Cs was crosslinked by 20 % PEGDAld with varying MW. The PEG graft 
density and length, and the concentration of PEG-g-Cs were controlled. Possible physical interaction 
mechanisms between varying MW of PEGDAld with (e) PEG750-g-Cs and (f) PEG2K-g-Cs. 
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When the PEG graft density was increased, 3 % PEG750(1)-g-Cs did not form hydrogel with any 
PEGDAld at the same concentration, but the hydrogels formed at all PEGDAld and the E showed the 
same biphasic dependence on MW of PEGDAld at higher concentration of 5 % PEG750(1)-g-Cs. At 
higher graft density, the reduced number of amine groups coupled with the increased steric hindrance 
by PEG grafts contributed to insufficient crosslinking, requiring higher concentration of PEG750(1)-
g-Cs for gelation. 
For PEG2K-g-Cs, the hydrogels did not form at 3 % with any PEGDAld. At 5 %, PEG2K(0.7)-g-Cs 
did form hydrogels with all PEGDAld, but the moduli were much lower than PEG750(0.7)-g-Cs at the 
same concentration (Figure 4-6b). The range of E for PEG2K-g-Cs became similar to that for 5 % 
PEG750-g-Cs when the concentration was increased to 8 %. These results indicated that higher graft 
length rendered PEG2K-g-Cs more limiting towards physical interaction with PEGDAld due to much 
greater steric hindrance, leading to insufficient crosslinking and hydrogels with lower mechanical 
properties (Figure 4-6f). In addition, the E increased with MW of PEGDAld at all conditions, rather 
than showing a maximum at intermediate MW of PEGDAld, which also indicated that shorter 
PEGDAld had greater difficulty of accessing amine groups of chitosan by increased steric hindrance 
of PEG2K grafts. 
In addition, when the graft density was increased, PEG2K(1)-g-Cs only formed a stable hydrogel with 
PEGDAld6K. Those crosslinked with PEGDAld2K and PEGDAld3.4 K quickly dissolved in buffered 
media, likely due to the critically low number of crosslinks being broken under highly hydrated 
environment, since Schiff base formation is a reversible equilibrium reaction which could revert back 
via hydrolysis. [81, 127] It should be noted that the hydrogels reported here in Figure 4-6 were all 
stable under neutral aqueous conditions because their degrees of crosslinking were significant enough 
to withstand possible hydrolysis. 
The effect of concentration of PEGDAld was also explored while keeping the PEG grafting constant 
(Figure 4-7). The hydrogels were successfully formed at a wide range of PEGDAld concentrations, as 
low as 5 %, for both PEG750(0.7)-g-Cs and PEG2K(0.7)-g-Cs, and the moduli were dependent on the 
crosslinker concentration. In addition, there was a gradual increase in moduli with MW of PEGDAld, 
which became more noticeable with increasing PEGDAld concentration. With increasing PEGDAld 
concentration, the effect of increased chain length of PEGDAld, which likely enhanced the crosslinking 
efficiency by overcoming the steric hindrance of PEG grafts, was more significantly demonstrated. 
For comparison, 3 % NCE-Cs was also crosslinked with varying MW of PEGDAld, and their moduli 
were measured. Compared to PEG750(0.7)-g-Cs at the same concentration, the moduli were 
significantly lower at all MW of PEGDAld (Figure 4-8a). Moreover, unlike PEG-g-Cs which showed 
either biphasic dependence or increased with MW of PEGDAld, the moduli decreased with MW of 
PEGDAld, in line with a more typical hydrogel system whose mechanics and crosslinking density are 
inversely related. This result further suggested that the PEG grafts on chitosan could significantly 
60 
 
improve the mechanical properties of Cs-PEG hydrogels by physical interaction (i.e. van der Waals 
force, chain entanglement) with PEGDAld crosslinkers (Figure 4-8b). 
 
Figure 4-7. Elastic moduli (E) of Cs-PEG hydrogels. (a) 5 % PEG750(0.7)-g-Cs and (b) PEG2K(0.7)-
g-Cs crosslinked by PEGDAld with varying MW and concentration. 
 
Figure 4-8. (a) Elastic moduli (E) of Cs-PEG hydrogels made by crosslinking NCE-Cs with varying 
MW of PEGDAld. (b) Possible mechanisms of PEGDAld interaction with PEG-g-Cs and NCE-Cs. 
4.3.3 Diffusional properties of Cs-PEG hydrogels 
With the ability to alter physicomechanical characteristics via PEGDAld crosslinking and PEG 
grafting, the diffusional properties of Cs-PEG hydrogels were expected to be tuned concurrently. To 
demonstrate the control of diffusional properties, the swelling ratios (Q) of the Cs-PEG hydrogels were 
first measured in conjunction with E shown in Figure 4-6a and b. Q and E generally demonstrated the 
typical inverse relationship, which was expected for an elastic network whose E and Q are governed 
by crosslinking density (ξ) (i.e. ζ ∝ E and ζ ∝ Q-1/3) (Figure 4-6c and d). [16, 30, 128] This result 
indicated that the Cs-PEG hydrogels are highly elastic, and their diffusional properties could be 
controlled by both MW of PEGDAld and PEG grafting of PEG-g-Cs. However, for 5 % PEG750(0.7)-
g-Cs, which showed greater degree of crosslinking by PEGDAld with higher MW, the E and Q both 
showed increase with MW of PEGDAld. It is inferred that the increased crosslinking efficiency by 
PEGDAld with higher MW resulted in increased E. At the same time, higher hydrophilicity and chain 
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length possibly allowed greater influx of water into the hydrogel, leading to increased Q. The porosity 
of Cs-PEG hydrogels was further evaluated by SEM (Figure 4-9a). At the given 5 % PEG750(0.7)-g-
Cs, the pore size generally increased with MW of PEGDAld. In addition, the pore size as substantially 
increased by increasing PEG graft length, PEG2K(0.7)-g-Cs. Overall, the pore size, as expected, 
coincided with Q. 
 
Figure 4-9. (a) Scanning electron microscopic visualization of pore networks of Cs-PEG hydrogels 
(scale bar: 50 μm). (b-e) Cumulative amount of BSA release profiles from Cs-PEG hydrogels, and 
kinetic constants (k) and exponents (n) obtained by fitting the profiles with a mathematical model (Eq. 
4-2); (b, c) PEG750(0.7)-g-Cs crosslinked with varying MW of PEGDAld, (d, e) different types of PEG-
g-Cs crosslinked with PEGDAld6K. 
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One critical advantage of hydrogel over other forms, such as films and textile, is the ability to safely 
encapsulate sensitive and bioactive therapeutic molecules and control their release kinetics through 
hydrogel mechanics. [7] Therefore, to assess the applicability of Cs-PEG hydrogels as a drug delivery 
system, drug release characteristics for Cs-PEG hydrogels were measured, using bovine serum albumin 
(BSA) as a model drug. The cumulative release profiles over time were measured, and they were fitted 
with a Ritger-Peppas model to obtain kinetic constants (k), which represent release rates, and exponents 
(n), which are related to release mechanisms (Figure 4-9). [43, 93, 95] First, when the MW of PEGDAld 
was controlled, while keeping the concentration at 20 %, to crosslink 5 % PEG750(0.7)-g-Cs, the 
release rates decreased with MW of PEGDAld, as expected, correlating inversely with the E values 
shown in Figure 4-6; lower release rates for highly crosslinked hydrogels (Figure 4-9b and c). It should 
be noted that the release rates decreased despite having higher Q values. Since the drug release rates 
obtained with the Ritger-Peppas model are largely determined by the initial rate, they were more 
heavily influenced by the degree of crosslinking than swelling which was determined later at 
equilibrium state. Increasing PEG graft length and density, which showed much lower E, resulted in 
increased release rates (Figure 4-9d and e). n values were not significantly affected by the MW of 
PEGDAld, and all in between 0.2 and 0.3, which was below 0.5 expected for pure Fickian diffusion. 
This “pseudo” Fickian diffusion suggested that the release was more expedited than simple diffusion, 
possibly due to the presence of PEG chains known for anti-fouling effect, combined with hydrophilic 
chitosan, facilitated the BSA release. 
 
4.3.4 Anti-microbial properties of Cs-PEG hydrogels 
In addition to the anti-microbial activities of PEG-g-Cs, as shown in Figure. 1e, those of Cs-PEG 
hydrogels were also evaluated by inoculating E. coil on the hydrogel surfaces. Agarose hydrogel 
surface, widely used to culture bacteria, was used as a positive control (Figure 4-10). The extensive E. 
coli growth on the agarose hydrogel was obviously evident. On the other hand, Cs-PEG hydrogels all 
showed much reduced bacterial growth, demonstrating their antimicrobial activities. At the same 5 % 
PEG750(0.7)-g-Cs, increasing MW of PEGDAld resulted in greater bacterial reduction. In addition, at 
the same MW of PEGDAld6K, increasing PEG graft length and density further diminished the bacterial 
growth on the hydrogels. These results demonstrated that the presence of PEG in the hydrogels, in the 
form of grafting or crosslinker, synergistically enhanced the anti-microbial activity likely due to the 




Figure 4-10. E. coli growth on various Cs-PEG hydrogel surfaces, visualized by staining with MTT, 
which turns live bacterial cells brown-purple. LB agarose hydrogel was used as a control. 
4.3.5 Gelation kinetics of Cs-PEG hydrogels 
The effects of MW and concentration of PEGDAld and the PEG graft length and density on the gelation 
kinetics to form Cs-PEG hydrogels were assessed by measuring rheological properties of the gel 
precursor solution of PEG-g-Cs and PEGDAld during the crosslinking reaction. The storage modulus 
(G’) and loss modulus (G’’) were measured over time to account for the elastic and viscous components, 
respectively. The gelation time, defined as the time for G’ and G’’ to cross, due to the increase in 
elasticity and the decrease in viscosity during gelation.  
At the PEG grafting density of 0.7, the gelation kinetics were not significantly affected regardless of 
PEG graft length and MW of PEGDAld, the gelation times were all within 60 seconds, especially 
considering the wide range of E of resulting Cs-PEG hydrogels from 3 to 35 kPa (Figure 4-11a, b and 
e). Since the concentrations of PEG-g-Cs and PEGDAld were the same, only changing the MW of 
PEGDAld did not significantly alter the number of reactive functional groups, as compared to changing 
the concentration, so the rate of crosslinking reaction was not significantly affected, especially with 
lower PEG grafting density allowing sufficiently facile physical interaction between PEG-g-Cs and 
PEGDAld. On the other hand, when the PEG grafting density was increased, there was a substantial 
difference in gelation time with the same PEGDAld (Figure 4-11c, d and f). This demonstrated that the 
physical interaction between PEG-g-Cs and PEGDAld became more restricted by increased graft 
length and density, leading to much further delayed crosslinking reaction. Taken together, barring the 
physically restrictive condition at the highest PEG grafting density the mechanical properties of Cs-
PEG hydrogels could be controlled in a wide range by MW of PEGDAld, while minimally affecting 




Figure 4-11. Rheological characterization of PEG-g-Cs and PEGDAld during gelation by measuring 
storage (G’) and loss (G’’): (a) PEG750(0.7)-g-Cs, (b) PEG2K(0.7)-g-Cs, (c) PEG750(1)-g-Cs, and (d) 
PEG2K(1)-g-Cs. In (c) and (d), PEGDAld6K was used. Gelation time for (e) PEG750-g-Cs and (f) 
PEG2K-g-Cs, determined by the time for G’ and G’’ curves to cross (identified with arrows). 
4.3.6 Tissue adhesive properties of Cs-PEG hydrogels 
Chitosan based materials have been widely investigated in topical wound care, combining 
biocompatibility, cost-effectiveness, mechanical durability, and anti-microbial activity, with several 
products already in the market. [105, 120, 130] In situ forming Cs-PEG hydrogels, with their ability to 
form in a biocompatible and timely manner, would ideally serve as sealants for wound closure 
applications. To allow stable adhesion to biological tissue, it is desirable to tune the physical properties 
of hydrogels for optimal interaction, which could be accomplished by varying the physical properties 
of PEG-g-Cs and PEGDAld. In addition, the Schiff base formation used to fabricate Cs-PEG hydrogels 
could further aid in tissue adhesion, as the proteins make up ECM contain abundance of amine groups 
that could participate in the crosslinking reaction. 
 To demonstrate the tissue adhesion properties of Cs-PEG hydrogels, lap shear tests using porcine 
skin tissue were first performed; Cs-PEG hydrogel was fabricated between two porcine skin tissue 
sections, which were then laterally pulled apart until the tissues were completely separated, and 
adhesion parameters, namely adhesive strength (σmax) and adhesive energy (JA), were measured (Figure 
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4-12a). At a given PEG750(0.7)-g-Cs or PEG2K(0.7)-g-Cs, both parameters showed gradual increase 
with MW of PEGDAld, coinciding with the compressive mechanical properties (Figure 4-12c and d). 
This highlighted that the increased mechanical rigidity of Cs-PEG hydrogels by greater extent of 
crosslinking generally enhanced their adhesion to biological tissues. Interestingly, increasing PEG graft 
length, from PEG750(0.7)-g-Cs to PEG2K(0.7)-g-Cs, had opposite effect on σmax and JA. More rigid 
PEG750(0.7)-g-Cs detached at higher stress than PEG2K-g-Cs hydrogels, and as a result σmax values 
of PEG750(0.7)-g-Cs hydrogels were generally higher than those of PEG2K-g-Cs hydrogels. However, 
since more rigid PEG750(0.7)-g-Cs hydrogels were also less resistant to deformation, they detached 
from the tissues at lower strain during lap shear conditions than PEG2K(0.7)-g-Cs hydrogels, resulting 
in lower overall adhesive energy (JA). In addition, there was more noticeable increase at PEGDAld6K, 
more so for JA than σmax, which coincided with the increase in modulus as shown in Figure 4-6a, 
demonstrating again that the increased mechanical strength of Cs-PEG hydrogels at the highest MW of 
PEGDAld contributed to stronger adhesion to biological tissue. At higher grafting density, varying the 
graft length from PEG750(1)-g-Cs to PEG2K(1)-g-Cs resulted in much greater reduction for both σmax 
and JA, also highlighting the difference in mechanical strength (Figure 4-12f-g). 
 
Figure 4-12. (a) Schematic illustrations of (a) a lap shear test and (b) a burst pressure test. Adhesive 
strength (σmax), adhesive energy (JA), and burst pressure (BP) of CsPEG hydrogels: (c, d, e) 
PEG750(0.7)-g-Cs and PEG2K(0.7)-g-Cs crosslinked with varying MW of PEGDAld, (f, g, h) 
PEG750(1)-g-Cs and PEG2K(1)-g-Cs crosslinked with PEGDAld6K. (*p < 0.05, n = 12). 
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The adhesive properties of Cs-PEG hydrogels were alternatively evaluated by burst pressure 
measurements, in which fluid pressure was applied to the Cs-PEG hydrogel attached to a tissue sample 
until the hydrogel became detached, and the maximum fluid pressure was measured (‘burst pressure 
(BP)’) (Figure 4-12b). Interestingly, unlike σmax and JA, BP was not significantly affected by the MW of 
PEGDAld, rather more substantially by the PEG graft length; BP values for PEG750(0.7)-g-Cs were 
much greater than those for PEG2K(0.7)-g-Cs at all MW of PEGDAld by as high as 4.4-fold (Figure 
4-12e). It is possible that the extended drag during the lap shear testing diminished the difference in 
adhesive strength (i.e. the drag between tissues and adhesives continues to occur even after initial 
detachment), whereas it became more evident in the instantaneous burst condition. Similar to σmax and 
JA, at higher grafting density, increasing the graft length PEG750(1)-g-Cs to PEG2K(1)-g-Cs resulted 
in significant reduction in BP (Figure 4-12h). Taken together, the adhesive strength of Cs-PEG 
hydrogels was strongly correlated with their mechanical properties, and there was a significant 
reduction at the highest PEG grafting density and length of PEG-g-Cs. 
The adhesive properties of a commercially available hydrogel-based tissue adhesive, Beriplast-P, was 
measured for comparison. Beriplast-P is a fibrin hydrogel prepared by crosslinking fibrinogen with 
thrombin. [131] E, σmax and JA for Beriplast-P from lap-shear tests were 17.3 (± 2.3) kPa, 1.73 (± 0.4) 
kPa, and 33.5 (± 4.1) mJ m-2, respectively. These values were comparable to the Cs-PEG hydrogel 
made with PEG750-g-Cs and PEGDAld6K, as shown in Figure 4-11. BP for Beriplast-P was measured 
at 8.4 (± 1.4) kPa, which was much lower than all Cs-PEG hydrogels with PEG750(0.7)-g-Cs, and 
comparable with that of PEG750(1)-g-Cs crosslinked with PEGDAld6K. These further highlighted the 
potential effectiveness of Cs-PEG hydrogels for clinical applications. 
 
4.3.7 In vivo evaluation of Cs-PEG hydrogel as tissue sealant 
The potential clinical application of Cs-PEG hydrogel as a tissue sealant was further evaluated using 
an in vivo skin wound model. A lateral incision was made on the skin of a SD rat, and Cs-PEG hydrogel 
was applied to close the wound via a syringe (Figure 4-13a). The Cs-PEG gel was readily formed and 
well attached to the skin. Three different Cs-PEG hydrogels were tested; (1) PEG750(0.7)-g-Cs, (2) 
PEG2K(0.7)-g-Cs, and (3) PEG2K(0.7)-g-Cs encapsulated with epidermal growth factor (EGF). EGF, 
a well-known promoter for wound healing, was included in the Cs-PEG hydrogel to demonstrate the 
advantage of hydrogel-based tissue sealant for the delivery of therapeutic biomolecules for accelerated 
wound healing. [132] Untreated, sutured, and Beriplast-P treated conditions were also tested as control 
groups. In addition to macroscopic visualization, the wound healing process was monitored in detail 
by OCT imaging (Figure 4-13b and c, Figure 4-15). The OCT imaging technology allows non-invasive 
in situ visualization of detailed skin tissue structure around the wound area with micrometer-scale 
resolution down to hypodermis. The wound dimensions, width and depth, were also quantified from 




Figure 4-13. (a) Cs-PEG hydrogel was applied to a rat skin wound model via syringe to close the wound 
gap. (b) OCT imaging was used to visualize the detailed skin tissue around the wound area. (c) After 
applying tissue sealants, the wound closure and subsequent healing process was monitored over time 
up to 5 days: (c-1) untreated, (c-2) suture, (c-3) Beriplast-P, (c-4) PEG750-g-Cs hydrogel, (c-5) PEG2K-
g-Cs hydrogel, (c-6) PEG2K-g-Cs hydrogel encapsulated with EGF. The markers on OCT images 




Figure 4-14. The wound dimensions, width and depth, measured from the OCT images (marked with 
arrows in Figure 4-13) 
 
Figure 4-15. Detailed schematics of Swept-Source Optical Coherence Tomography (SS-OCT) imaging 
apparatus to visualized skin tissue; C: Collimator, L: Lens, RM: Reference mirror, FC: Fiber coupler, 
CIR: Circulator, BPD: Balanced photo-detector, GS: Galvanometer scanner. 
Without any sealant (‘untreated’), the wound gap was wide enough that it did not close naturally, and 
the scab formed on the wound area, with erythema surrounding the area, as expected. The suture 
allowed the gap to close tightly, and significant wound healing took place by day 3, though suture scar 
remained up to 5 days. Beriplast-P as a hydrogel tissue sealant also helped close the wound gap, but 
there was some inflammation surrounding the wound site, as identified by erythema and swelling which 
eventually subsided and healed by day 5. The OCT image clearly visualized the difference in tissue 
texture underneath the wound site; higher reflection signals caused by denser tissue structure, compared 
to normal tissue. Since OCT utilize the scattering contrast for imaging, higher reflection signal of OCT 
image presenting bright regions indicated higher tissue density, likely fibrotic tissue. The early 
inflammation of fibrin-based Beriplast-P has been associated with the immunological response 
stemming from allogenic source. [131] But the biological effect of fibrin, a protagonist for wound 
healing, likely expedited the process. 
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For PEG750-g-Cs, the initial wound gap closure was similar to Beriplast-P, but there was less 
inflammation, while the wound healing was slower. More remarkably, there was a greater degree of 
wound closure and less inflammation after day 1 was shown for PEG2K-g-Cs, more so than Beriplast-
P and PEG750-g-Cs. One critical difference of PEG2K-g-Cs from PEG750-g-Cs was more sustained 
water retention, since PEG2K-g-Cs hydrogel has higher degree of swelling. Therefore, it was inferred 
that continued presence of moisture provided by PEG2K-g-Cs hydrogel substantially reduced the 
inflammation. [133] PEG750-g-Cs, on the other hand, more quickly dried out over the same time period. 
To further illustrate the advantage of Cs-PEG hydrogel as a drug delivery system, epidermal growth 
factor (EGF), a growth factor involved with wound healing process, was encapsulated to be released 
to the wound area, expediting the wound healing process. The macroscopic view of the wound area 
was similar to that without EGF. But the OCT image showed less signal intensity at the wound site, 
suggesting there was less fibrotic tissue formed by the action of released EGF. 
Detailed tissue morphology during the wound healing process after tissue sealant application was 
further histologically evaluated (Figure 4-16). The H&E stained histological tissue images largely 
confirmed the inflammation and fibrotic tissue formation by OCT imaging. Untreated and Beriplast-P 
treated tissues showed the highest degree of fibrosis. PEG750-g-Cs and PEG2K-g-Cs treated tissues 
showed less fibrosis than Beriplast-P. Moreover, EGF encapsulated PEG2K-g-Cs treated tissue showed 
the least amount of fibrosis. Taken together, these results highlighted that the Cs-PEG hydrogel, 
coupled with controlled release of a therapeutic agent, highly effective as a tissue sealant. 
 
Figure 4-16. Histological evaluation of the skin wound tissues after tissue sealant treatment. The tissues 
harvested at day 3 and 5 were stained with hematoxylin & eosin (scale bar: 500 μm). E: epidermis, D: 




In this study, in situ forming chitosan hydrogel, via Schiff base formation, capable of controlling 
mechanical properties in a wide range without compromising gelation kinetics was developed. 
Chitosan was conjugated with PEG grafts with controlled length and density (PEG-g-Cs) not only to 
allow aqueous solubility at physiological pH, but more importantly to modulate physical interaction 
with varying MW of polymeric crosslinker, PEG-dialdehyde (PEGDAld), which directly influenced the 
mechanical outcome of the resulting Cs-PEG hydrogels. The gelation kinetics, determined from 
rheological evaluation, showed that all hydrogels, except at the highest PEG graft length and density, 
were readily formed (within a minute). The adhesive properties of Cs-PEG hydrogels evaluated by ex 
vivo lap shear and burst pressure tests were generally in line with the mechanical properties, and were 
similar to a commercial hydrogel-based tissue sealant. The clinical potential of Cs-PEG hydrogels as a 
tissue adhesive was demonstrated with an in vivo rat skin wound model, which showed wound closure 
with minimal inflammation. More significantly, controlled release of EGF from Cs-PEG hydrogel 
significantly reduced the inflammation, effectively demonstrating an important advantage of 
therapeutic delivery for hydrogel-based tissue sealant. 
 
Reprinted (adapted) with permission from (M. Kim, et al, Carbohydrate Polymers, 2020, 229, 115538). 




CHAPTER 5. In situ facile-forming chitosan hydrogels with 
tunable physicomechanical and tissue adhesive properties by 
polymer graft architecture 
 
5.1 Introduction 
Controlling mechanical properties is a major research focus in the field of biomaterials. The materials 
used in various biomedical applications, including tissue engineering, drug delivery, biosensors, and 
actuators, must possess sufficient structural integrity and durability throughout their intended lifetimes 
in order to maintain their performance. In addition, it is well established that physicomechanical signals 
imparted by the extracellular matrices influence important biological functions of many different types 
of cells; thus, it is of significant importance that biomaterials as cell culture platforms should have 
tunable mechanical properties. [134-138] Mechanical properties are also directly connected to 
permeability, which controls the diffusion of soluble factors through the biomaterials, which is an 
important parameter for controlled drug delivery and 3D cell culture applications. [57, 134, 135] 
Polymers with multivalent reactive functional groups, often called macromers, have been considered 
highly effective cross-linkers to develop materials with variable mechanical properties over 
conventional small molecular cross-linkers. [30, 93, 109, 136, 137] Small molecules can only have a 
few functional groups and often show limited solubility in various solvents, limiting their controllable 
range. On the other hand, polymers that have functional groups throughout their repeating units serving 
as sites for chemical reactions can present more reactive functional groups than small molecules, 
further increasing the range of control per concentration. In addition, adding reactive functional groups 
to a long polymer chain usually does not impact the overall solubility. The macromers having self-
reacting moieties such as (meth)acrylate that undergo radical cross-linking and can cross-link by 
themselves to form structures above threshold concentrations without the need for additional cross-
linkers. Conversely, macromers can easily hybridize with one another, provided their physicochemical 
miscibility and mutual reactivity. 
Polysuccinimide (PSI), commonly synthesized by one-step polycondensation of aspartic acid, has 
been shown to be a good precursor system for conjugating various functional groups. [138-141] 
Specifically, amine-based nucleophiles react with succinimidyl groups of PSI via ring-opening addition, 
resulting in polyaspartamide. Previous studies have demonstrated that polyaspartamide can be utilized 
as a gel-forming polymer and cross-linker by presenting reactive functional groups such as amine, thiol, 
and methacrylate. [93, 142-145] Furthermore, convenient control of the degree of substitution allows 
the control of cross-linking density in addition to changing the concentration. 
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In our previous work, it was demonstrated that polyaspartamide presenting amine or hydrazide groups 
could form hydrogels having controllable mechanical properties by Schiff base formation or Michael 
addition, based on the degree of substitution. [93] However, the influence of physical properties of 
polyaspartamide on the hydrogel mechanics has not been explored. Therefore, herein, the grafting 
parameters, graft density, and length of reactive functional groups of polyaspartamide cross-linkers 
were modulated in order to control the mechanical properties of resulting hydrogels. Polyaspartamide 
presenting primary amine groups was developed by reacting PSI with diamine with poly(ethylene 
glycol) (PEG) linkers having varying lengths. PEG-diamine with varying molecular weights were 
synthesized and used to present amine groups on the polyaspartamide backbone. The resulting poly(2-
hydroxyethyl aspartamide)-g-amino-poly(ethylene glycol) (PHEA–PEGAm) was then reacted with 
aldehyde-presenting alginate via Schiff base to develop hydrogels. The length of PEG linker and the 
degree of amine substitution were varied to control the mechanical properties of hydrogels. Moreover, 
the unreacted amine groups on PHEA–PEGAm facilitated the degradation and eventual dissolution of 
hydrogels via hydrolysis under physiological conditions, and the rate of degradation was also controlled 
by the grafting parameters. The biomedical potential of this hydrogel as a tissue injectable and 
degradable delivery system was demonstrated using an ex vivo model. To further control the 
degradation and mechanics, the alginate component of hydrogels was additionally cross-linked with 
divalent calcium ions. 
 
5.2 Materials and Methods 
5.2.1 Synthesis of Polysuccinimide (PSI) 
Polysuccinimide (PSI) was prepared by polycondensation of aspartic acid with phosphoric acid as an 
acidic catalyst. [93, 142-145] l-Aspartic acid (50 g, Samchun Chemicals, Korea) and orthophosphoric 
acid (1.22 mL, Sigma-Aldrich) were dissolved in sulfolane (130 mL, Junsei Chemical, Japan) and 
refluxed at 180 °C with mechanical stirring under dry N2. Water formed during the reaction was 
continuously removed using a Dean–Stark trap. After 7 h, the red-orange-colored reaction mixture was 
precipitated with methanol. The precipitate was washed with deionized water several times and dried 
to obtain the final product. 
 
5.2.2 Synthesis of PEG-Diamine 
Poly(ethylene glycol) diamine (PEG-diamine) was synthesized by direct amination of PEG (Mw 200, 
600, and 1000, Sigma-Aldrich) via Mitsunobu reaction. [146] Briefly, diisopropyl azodicarboxylate 
(DIAD, Alfa Aesar) dissolved in 1,4-dioxane was slowly added via syringe to an ice-cooled 
triphenylphosphine (Ph3P, Sigma-Aldrich) solution and mixed for 1 h. PEG was dissolved separately 
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in dry 1,4-dioxane (Samchun Chemicals, Korea) under dry N2 gas. Then, PEG solution was slowly 
added to the DIAD/Ph3P solution and stirred until it became clear. Phthalimide (Sigma-Aldrich) was 
added to the mixture and stirred overnight at 50 °C under N2. The molar ratio of 
PEG/DIAD/TPP/phthalimide was 1:3:3:3. 
After the conjugation of phthalimide, hydrazine (Alfa Aesar) was added to the mixture in 15-fold 
access and refluxed for 3 h to remove the phthalimide and generate amine on PEG. After the reaction, 
the mixture was completely dried in vacuo 60 °C to obtain the crude product. Subsequently, the crude 
product was dissolved in ice-cooled water to remove the water-insoluble impurities via filtration. The 
same procedure was repeated using HCl (5 M). The filtered solution was neutralized using NaOH (5 
M), and the final product was obtained by freeze-drying. The chemical structure of PEG-diamine was 
analyzed with 1H NMR (Figure 5-1). The degree of amination was verified using a colorimetric 
trinitrobenzenesulfonic acid (TNBS) assay, which measures the amount of amine and related molecular 
weight (Figure 5-2). [93, 147] 
 
Figure 5-1. 1H-NMR spectra of PEG-diamine with varying molecular weights; 200, 600, 1000 (1K) g 




Figure 5-2. The amount of amine in (a) PEG-diamine and (b) PHEA-PEGAm600 with varying DSAm 
determined by TNBS assay (absorbance at 335 nm). 
5.2.3 Synthesis of Poly(2-hydroxyethyl aspartamide)-g-Amino-Poly(ethylene glycol) (PHEA–
PEGAm) 
PHEA–PEGAm, presenting varying amounts of hydroxyl and amine groups are synthesized by 
reacting PSI with ethanolamine and PEG-diamine, respectively. [93] First, ethanolamine (Sigma-
Aldrich) was added to PSI (1 g) dissolved in 20 mL of dimethyl sulfoxide (DMSO, Samchun Chemicals, 
Korea) and reacted overnight at 70 °C under dry N2 gas to synthesize an intermediate polyaspartamide 
containing hydroxyl and unreacted succinimidyl groups, poly(2-hydroxyethyl aspartamide) (PHEA). 
Ethanolamine was reacted before PEG-diamine because unreacted PSI with numerous succinimidyl 
groups can react with both amine groups of PEG-diamine, resulting in cross-linking of PSI chains. The 
amount of ethanolamine was determined so the number of remaining unreacted succinimidyl groups to 
be reacted with PEG-diamine was the desired degree of amine substitution. Then, the mixture was 
slowly added to PEG-diamine dissolved in DMSO and continued to react at 70 °C for 48 h. The 2-fold 
excess amount of PEG-diamine to that of unreacted succinimidyl groups was used to ensure only one 
amine group of PEG-diamine reacted with the succinimidyl groups of PHEA, and the other amine 
group was not reacted. After reaction, the mixture was dialyzed against DI water and lyophilized to 
obtain product. 
PHEA–PEGAm with different degrees of amine substitution (DSAm), defined as the fraction of 
succinimidyl groups conjugated with amine groups, were obtained by simply varying the PEG-diamine 
reactant. As a control, PHEA presenting short aminoethyl grafts, PHEA–PEGAm, were also 
synthesized by using ethylenediamine instead of PEG-diamine. The chemical structure and DSAm of 
PHEA–PEGAm were analyzed with FT-IR and 1H NMR spectroscopies. As a control system without 
PEG linker, PHEA presenting aminoethyl groups, PHEA-EtAm, was synthesized following the same 




5.2.4 Trinitrobenzene sulfonic acid (TNBS) assay 
0.1 mL of TNBS working solution (0.5 % TNBS, 4 % NaHCO3, pH 8.5) was added to 0.1 mL of sample 
solution (PEG-diamine or PHEA-PEGAm) and allowed to react for 2 hours at 37 °C. After the reaction, 
0.1 mL of 1 M HCl was added. The absorbance of the solution at 335 nm was measured (Multiskan GO, 
Thermo Fisher Scientific). 
 
5.2.5 Synthesis of oxidized alginate 
Sodium alginate (Sigma Aldrich) was dissolved in deionized water at 1 %. 0.43 g sodium periodate 
was added to the solution and reacted with stirring at room temperature for 24 hours under dark. After 
quenching the reaction with excess ethylene glycol, the solution was extensively dialyzed against DI 
water, and freeze-dried to obtain the product. [148, 149] 
 
5.2.6 Fabrication of PHEA–PEGAm Hydrogels 
Alg-PHEA hydrogel was fabricated by reacting PHEA–PEGAm with alginate presenting aldehyde 
groups (Alg-ALD) via Schiff base formation. [148, 149] PHEA–PEGAm and Alg-ALD solutions in 
0.1 M sodium phosphate buffer (pH 8.0), were mixed in various ratios. The mixture was immediately 
placed in between glass plates with 1 mm spacer and incubated at 37 °C to allow hydrogels to form. 
The hydrogel disks (8 mm diameter, 1 mm thickness) were punched out, and mechanical properties 
were determined. To induce secondary ionic cross-linking, Alg-PHEA hydrogel was immersed in 
CaCl2 solution for 1 h with gentle shaking. The concentration of CaCl2 was controlled up to 5 M. 
 
5.2.7 Mechanical and Degradation Properties of Hydrogels 
The rigidity of hydrogels was evaluated by calculating elastic moduli obtained from uniaxial 
compression experiments (Model 3343, Instron). [29, 94, 150] The pressure applied to each hydrogel 
at the rate of 1 mm min–1 and the stain versus stress curve were obtained. The elastic modulus was then 
determined as the slope of the strain–stress curve at the first 10% strain in the linear curve region (the 
elastic region). 
The degradation behavior was monitored by measuring the change in elastic moduli over time. The 
hydrogels were incubated in PBS at 37 °C, and their moduli were analyzed at designated time points 
until the hydrogel were completely dissolved. The degradation rate constant (kD) was obtained by fitting 
the fractional change in moduli versus time curve with the following exponential decay model: 
𝐸𝑡
𝐸0
= 𝑒−𝑘𝑑∙𝑡    Eq. 5-1 
where Et was the modulus measured at time, t, and E0 was the initial modulus measured immediately 
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after formation. [74, 94] 
 
5.2.8 Drug Release Kinetics 
Drug release kinetics from hydrogels were measured using bovine serum albumin (BSA, Sigma-
Aldrich) as a protein drug model. Before the hydrogel fabrication, BSA (5 mg mL–1) was dissolved in 
the PHEA–PEGAm precursor solution for encapsulation. Then, each hydrogel disk was incubated in 
PBS (0.8 mL) at 37 °C, and the protein released into the medium was measured at various time points 
using a BCA Protein Assay kit (Thermo Fisher) according to the manufacturer’s instructions. The 
cumulative drug release profile was fitted to the Ritger-Peppas equation, 
𝑀𝑡
𝑀0
= 𝑘𝑅 ∙ 𝑡
𝑛
    Eq. 5-2 
where Mt was the amount of protein released at a time, t, M∞ was the total amount of encapsulated 
protein, kR was the release rate constants, and n was the exponent related to the release mechanism. [94, 
95, 151] 
 
5.2.9 Rheological Properties of Hydrogels 
The gelation kinetics of Alg-PHEA hydrogels were evaluated using a rotating-disk rheometer 
(Kinexus, Malvern). [72, 73] After mixing Alg-ALD and PHEA–PEGAm solutions, the changes in the 
storage moduli (G′) and loss moduli (G″) of the mixture was performed at the same strain (1%) and 
cyclic frequency (1 Hz) in a small-amplitude oscillatory shear mode. The gelation time was determined 
by the time at which G′ exceeded the G″ curve (gelation point) due to the elastic component increased 
rapidly as the cross-linking reaction proceeded. 
 
5.2.10 In Vitro Cytotoxicity 
Cytotoxicity of PHEA and Alg-ALD was assessed by measuring the viability of cells exposed to 
PHEA and Alg-ALD with varying concentrations with MTT assay. Briefly, NIH 3T3 fibroblasts (ATCC) 
were cultured in a 96-well plate, 2000 cells per well, and incubated at 37 °C for 36 h. The cell culture 
medium consisted of 10 % fetal bovine serum and 1 % penicillin/streptomycin in Dulbecco’s Modified 
Eagle Medium (DMEM), all purchased from Thermo Fisher Scientific. After the cells reached 50 % 
confluence, the medium was exchanged with that containing various concentrations of PHEAA and 
OAlg, and cultured at 37 °C for 36 h. After washing with PBS, the cells were incubated in 100 μL of 
fresh culture medium added with 10 μL of MTT solution (5 mg mL–1, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) in PBS) and at 37 °C for 4 h, during which MTT was 
enzymatically converted to formazan, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan, in 
proportion to the live cells. A total of 100 μL of the stop solution (20 % sodium dodecyl sulfate in 
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water/dimethylformamide (50:50)) was added to dissolve the formazan. The absorbance of the 
resulting colored solution at 570 nm was measured (Multiskan GO, Thermo Fisher). 
 
5.2.11 Ex Vivo Evaluation of Degradation Behavior of Hydrogel 
The degradation behavior of Alg-PHEA hydrogels injected inside a tissue environment was evaluated 
ex vivo using porcine liver explants (purchased from Biozoa Biological Supply Co., Korea). [152] 
Briefly, 150 μL of hydrogel precursor solution, prepared by mixing Alg-ALD and PHEA solutions, 
were injected into the center of a liver specimen (10 mm × 10 mm each) and incubated at 37 °C for 10 
min to allow hydrogel formation. Subsequently, the specimens were swollen with 10 % neutral buffered 
formalin solution for a designated time, and then each specimen was cut in half to take microscopic 
images of the cross-section and harvested for histological evaluation. Hematoxylin and eosin (H&E) 
staining was performed on the frozen tissue sections. 
 
5.3 Results and Discussion 
5.3.1 Synthesis and Characterization of Amine-Presenting Polyaspartamide with Tunable Graft  
Architecture 
Polysuccinimide is a uniquely structured polymer consisting of a series of succinimidyl ring structures 
that can undergo ring-opening nucleophilic addition with amine-based nucleophiles, resulting in a 
stable β-polypeptide, termed polyaspartamide. This property allows the conjugation of various 
functional groups to the polyaspartamide backbone. In this study, polyaspartamides presenting different 
amounts of amine groups were prepared. Starting from PSI, which was synthesized by 
polycondensation of aspartic acid, it was first reacted with ethanolamine to present hydroxyl groups, 
then followed by reaction with poly(ethylene glycol) (PEG) diamine to the remaining succinimidyl 
groups (Figure 5-3a). PEG-diamine was developed from PEG having hydroxyl end groups via 
Mitsunobu reaction (Figure 5-1, Figure 5-2a, and Figure 5-3b). The length and density of amine grafts 
of the resulting poly(2-hydroxylethyl aspartamide)-g-amino-poly(ethylene glycol) (PHEA–PEGAm) 
could be conveniently tuned by PEG-diamine with varying degrees of substitution (DSAm) and 
molecular weights (Figure 5-3c). Three different molecular weights of PEG-diamine were used: 200, 
600, and 1000 g mol–1, which were denoted as PHEA–PEGAm200, PHEA–PEGAm600, and PHEA–
PEGAm1K, respectively. It should be noted that PEG-diamine with a higher Mw, 2000 and 6000 g mol–
1, was also prepared, but it did not lead to sufficient grafting and subsequent gelation, likely due to low 




Figure 5-3. (a) Synthesis of poly(2-hydroxylethyl aspartamide)-g-amino-poly(ethylene glycol), termed 
PHEA–PEGAm, via ring-opening addition of polysuccinimide (PSI) with ethanolamine and PEG-
diamine. (b) Synthesis of poly(ethylene glycol)(PEG) diamine via Mitsunobu reaction of PEG. (c) 
Schematic illustration of controlling the length and density of amine grafts of PHEA–PEGAm. 
The chemical structures of PHEA–PEGAm with varying DSAm and graft length were analyzed 
with 1H NMR and FT-IR spectroscopy (Figure 5-4 and Figure 5-5). The peaks corresponding to 
hydroxyl and amine grafts varied accordingly with the DSAm. TNBS assay, which determines the 
amount of primary amine groups, was also employed to verify the DSAm (Figure 5-2b). In addition, the 
different lengths of PEG linker at the same DSAm could also be confirmed with 1H NMR spectroscopy. 
These results all confirmed the convenient control of graft length and DSAm of PHEA–PEGAm 




Figure 5-4. 1H-NMR spectra of PHEA-PEGAm with varying DSAm; (a) PHEA-PEGAm200, (b) 
PHEAPEGAm600 and (c) PHEA-PEGAm1K. Characteristic peaks corresponding to hydroxyl grafts 




Figure 5-5. Representative FT-IR spectra of PHEA-PEGAm with varying DSAm. Characteristic peaks 
corresponding to amide vs(C=O) of hydroxyl grafts (a) and amine grafts (b) are noted. 
The cytotoxicity of PHEA–PEGAm was assessed in vitro by exposing fibroblasts with varying 
concentrations of PHEA–PEGAm, from the nano to the millimolar range (Figure 5-6). All three PHEA–
PEGAm showed significant biocompatibility, with cell viability over 80%, even at a high concentration 
of 1 mg mL–1. It is interesting to note that, at the highest concentration tested, at 10 mg mL–1, cell 
viability against PHEA–PEGAm200 was significantly reduced compared to PHEA–PEGAm600 and 
PHEA–PEGAm1K, indicating the introduction of longer PEG chains, well-known to have high 
biocompatibility, helped improve the biocompatibility of PHEA–PEGAm. [153] 
 
Figure 5-6. Cytotoxicity of PHEA-PEGAm assessed by measuring the viability of cells exposed to 
various concentrations of PHEA-PEGAm. 
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5.3.2 Fabrication and Mechanical Properties of PHEA-Linked Hydrogels 
To demonstrate the ability of PHEA–PEGAm to react with other polymers to form hydrogels and 
control their mechanical properties with DSAm, PHEA–PEGAm was reacted with aldehyde-presenting 
alginate (Alg-ALD) to induce Schiff base formation. The resulting “Alg-PHEA” hydrogels were 
generated under mild physiological buffered conditions without any additional chemical treatments. 
Their mechanical properties were evaluated by measuring elastic moduli obtained from uniaxial 
compression. Hydrogels made with PHEA-EtAm without PEG linker were also evaluated as a control 
to further delineate the effect of graft length on hydrogel mechanics. The concentration of Alg-ALD 
was kept at 5%, while PHEA was varied from 10 to 20%. 
The hydrogels made with PHEA-EtAm as a control showed increased moduli with increasing 
concentration at all DSAm, as expected (Figure 5-7a). However, the moduli showed a gradual decrease 
from DS1 to DS3, despite the increase in DSAm, while a further increase in DSAm from DS3 to DS5 
resulted in an expected increase in moduli. This initial decrease in moduli with DSAm may have been 
due to the conformational change with an initial increase in amine content, possibly chain collapse, 
before a further increase in amine groups allowed more extensive cross-linking with more amine groups 
extending outward (Figure 5-8a). This explanation is based on a previous study by Hou et al. 
demonstrating that a polypeptide consisting of different ratios of amine-presenting lysine and hydroxyl-
containing threonine induced conformational changes, in which increasing lysine content increased α-
helical and secondary coil structures having amine groups outward. [154] 
 
Figure 5-7. Elastic moduli (E) of Alg-PHEA hydrogels controlled with DSAm of PHEA, (a) PHEA-




Figure 5-8. Schematic illustration of possible mechanisms of cross-linking reactions: (a) PHEA-
EtAm or PHEA–PEGAm200 with varying DSAm; (b) PHEA–PEGAm with varying graft lengths. 
On the other hand, the hydrogels made with PHEA–PEGAm200 showed a gradual increase in moduli 
from DS1 to DS4 at 15 and 20%, and they were much higher than those with PHEA-EtAm at the same 
concentration and DSAm (Figure 5-7b). This demonstrated that the increased amine graft length likely 
extended the polymer chains and helped reach the reactive aldehyde on alginate, leading to a greater 
degree of reactions (Figure 5-8a). Interestingly, however, the hydrogel did not form at the lowest DSAm 
(DS1 and DS2) at the lowest concentration of 10%. Reduced reactive sites at low DSAm combined with 
a higher molecular weight between cross-links due to longer graft lengths likely prevented extensive 
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cross-linking and subsequent hydrogel formation. 
Further increase in amine graft length of PHEA–PEGAm resulted in continued decrease in hydrogel 
rigidity, at all concentrations and DSAm (Figure 5-7c and d). Also, the hydrogel did not form at DS1 
and DS2 at all concentrations. These results clearly indicated that increasing graft length significantly 
hindered the effective cross-linking between Alg-ALD and PHEA–PEGAm. Due to the longer graft 
pushing the polymer chains farther apart, leading to an insufficient degree of cross-linking for hydrogel 
formation at lower DSAm or hydrogels with substantially lower mechanical rigidity at higher DSAm 
(Figure 5-8b). It is also plausible that longer amine grafts have diminished reactivity owing to their 
reduced mobility and steric hindrance. [71, 155] It should also be noted that the moduli all decreased 
at the highest DSAm (DS5) for all PHEA–PEGAm, likely due to the stoichiometric access of amine 
groups reversing the Schiff base formation. Taken together, the graft architecture of PHEA–PEGAm, 
namely, graft length and degree of substitution of reactive groups, heavily influences the cross-linking 
reaction between gel-forming polymers, leading to the formation of hydrogels with varying mechanical 
properties. 
The gelation kinetics of Alg-PHEA hydrogels were also assessed by measuring the gelation time (tgel) 
(Figure 5-9). tgel decreased with DSAm and concentrations of PHEA-EtAm and PHEA–PEGAm, as 
expected, since having a greater number of reactive functional groups expedites the cross-linking 
reactions. At the lowest concentration of 10%, tgel was more varied with DSAm, compared to those at 
higher concentrations of 15 and 20%, in which tgel was more consistent despite the change in DSAm at 
the same concentration. Increasing graft length also significantly increased tgel, as the decreased 
conformational mobility due to longer PEG linker reduced the rate of cross-linking reaction. This result 
suggested that varying DSAm at a given polymer concentration could more effectively keep the gelation 




Figure 5-9. Gelation time (tgel) of Alg-PHEA hydrogels controlled with concentration and DSAm of 
PHEA, (a) PHEA-EtAm, (b) PHEA–PEGAm200, (c) PHEA–PEGAm600, and (d) PHEA–PEGAm1K. 
5.3.3 Degradation of PHEA-Linked Hydrogels 
Regardless of mechanical properties, all Alg-PHEA hydrogels explored herein underwent facile 
dissolution in neutral buffered solutions within 10 h. Hydrogels formed via reversible Schiff base 
formation can undergo reverse dissociation. But since Schiff base is highly favored for hydrogels that 
are readily formed, they do not generally undergo spontaneous degradation under physiological 
environment (neutral pH, mild temperature). This highly interesting degradation behavior of PHEA-
linked hydrogel system is driven by the remaining unreacted amine groups undergoing nucleophilic 
attack directly or increasing the basicity of the local environment via protonation, resulting in the 
reversal of Schiff base linkage, which has been similarly demonstrated in previous studies. [65, 71, 93, 
156, 157] 
To evaluate the effect of graft length and DSAm on the rate of degradation, the Alg-PHEM hydrogels 
were incubated in PBS and the change in elastic moduli were measured over time (Figure 5-10a–c). 
The degradation rate constants (kD) were obtained by fitting the plots with an exponential decay model 
(Eq. 5-1; Figure 5-10d–f). For both PHEA–PEGAm200 and PHEA–PEGAm600, the degradation rate 
generally increased with DSAm and concentration, despite having greater mechanical rigidity, as shown 
in Figure 5-7. This result showed that the degree of swelling did not directly correlate with the 
degradation and identified that the degradation was clearly promoted by the amine grafting; having a 
greater number of amine groups, either by DSAm or concentration, facilitated the degradation. It further 
corroborated the previous findings that having multiple, unreacted amine groups facilitate the reverse 
hydrolysis of Schiff base linkage. This decoupled behavior of mechanics and degradation of PHEA-
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linked hydrogels does not follow most degradable hydrogel systems via hydrolysis in which the 
degradation rates correspond with the degree of swelling that expedites the hydrolysis. Therefore, this 
allows the fabrication of hydrogels with widely controllable mechanics that have comparable 
degradation rates. 
 
Figure 5-10. Time-resolved fractional change in elastic moduli (Et/E0) and degradation rates (kD) of 
Alg-PHEA hydrogels: (a, d) PHEA–PEGAm200, (b, e) PHEA–PEGAm600, and (c, f) PHEA–
PEGAm1K. 
For PHEA–PEGAm1K, on the other hand, the degradation rate decreased with increasing DSAm and 
concentration. This opposite effect of amine graft could be attributed to the substantially increased 
portion of PEG buffering the effect of end amine groups expediting the hydrolysis of Schiff base 
linkage. As a result, the hydrogels with lower mechanical rigidity showed greater rate of degradation. 
The buffering effect of PEG linkers that delays the amine-induced hydrolysis was further corroborated 
by the fact that all hydrogels cross-linked with PHEA-EtAm without PEG linkers completely dissolved 
within 1 h, regardless of concentration and DSAm (data not shown). 
It is fascinating to note that, regardless of hydrogel mechanics that varies widely, all PHEA-linked 
hydrogels underwent complete dissolution in relatively short times, mostly within a few hours. It is 
believed that the cross-links formed by Schiff base linkage that became extensively reversed by the 
combination of high water content via swelling and the free amine groups facilitating a nucleophilic 
attack. [93, 156] In addition, it has been proposed that the amide bonds of the polyaspartamide 
backbone undergo deamidation by the side chain amine or amide, leading to the main backbone 




5.3.4 Drug Release Kinetics of PHEA-Linked Hydrogels 
This highly unique hydrogel system that can decouple the mechanical properties and degradation 
could be viewed as an ideal drug delivery system that allows for both minimally invasive injectability 
and facile degradation. Therefore, the drug release profiles of Alg-PHEA hydrogels using BSA as a 
model drug were measured over time (Figure 5-11a–d), and then they were fitted with the Ritger-
Peppas model (Eq. 5-2) to obtain drug release rate constants (kR; Figure 5-11e–h). 
 
 
Figure 5-11. Time-resolved fractional drug release profiles (Mt/M∞) and release rate constants (kR) of 
Alg-PHEA hydrogels: (a, e) PHEA–PEGAm600 (DS4), (b, f) PHEA–PEGAm1K (DS4) with varying 
concentrations, (c, g) 15% PHEA–PEGAm600 with varying DSAm, and (d, h) 15% PHEA–PEGAm 
(DS4) with varying graft lengths. Elastic modulus (E) and degradation rate constant (kD) for each 
condition are noted. 
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For both PHEA–PEGAm600 and PHEA–PEGAm1K at DS4, kR decreased with increasing 
concentration, as expected, since drug release is generally slower in more rigid hydrogels having a 
higher degree of cross-linking. However, kR values did not correlate with kD, in which hydrogels with 
a faster degradation (higher kD) are expected to facilitate quicker drug release (higher kR). In fact, for 
PHEA–PEGAm600, the trend of kR was opposite to that of kD. Since the drug release from hydrogels 
under aqueous conditions is mostly governed by an initial diffusion, as evidenced by the exponent (n) 
values obtained from the Ritger-Peppas model all below 0.5, the subsequent degradation did not have 
a significant effect on the drug release (Figure 5-12). [151] 
 
Figure 5-12. Exponent (n) values obtained by fitting the time-resolved drug releases of Alg-PHEA 
hydrogels with Eq. 5-2 (Ritger-Peppas model): (a) PHEA-PEGAm600 (DS4), (b) PHEA-PEG1K (DS4) 
with varying concentrations, (c) 15 % PHEA-PEGAm600 with varying DSAm, and (d) 15 % 
PHEAPEGAm (DS4) with varying graft lengths. 
On the other hand, varying the DSAm of Alg-PHEA hydrogels at the same concentration (15%) of 
PHEA–PEGAm600, kR indeed increased with kD and did not correlate with mechanics. Furthermore, 
at a given DSAm and concentration, increasing from PEGAm600 to PEGAm1K significantly increased 
kR, as expected, having lower mechanical properties. But kR was higher at PEGAm200 having higher 
mechanical properties and lower degradation rates. It was speculated that having shorter PEG chains 
could more easily move and change their conformations within the hydrogels, facilitating the protein 
release. Taken together, these results alluded to the role of amine grafts in facilitating the drug release 




5.3.5 Ex Vivo Alg-PHEA Hydrogel Injection and Degradation 
The in situ forming and fast degrading Alg-PHEA hydrogel system is ideally suited for tissue 
injectable delivery system. To highlight the injectability and degradability within tissue environment, 
Alg-PHEA precursor solution was injected into an animal tissue explant model, and in situ hydrogel 
formation and dissolution were monitored (Figure 5-13a). 
 
Figure 5-13. (a) Schematic representation of Alg-PHEA hydrogel injection into a tissue explant and 
subsequent degradation in neutral buffered solution. (b) Representative H&E histological images of 
Alg-PHEA hydrogel formed within tissue (left) and the same tissue area after hydrogel dissolution in 
24 h (right; scale bar: 100 μm). (c) H&E histological images (top) and photographs (bottom) of various 
Alg-PHEA hydrogels within tissues after 4 h (scale bar: 100 μm). Boxed sections in photographs show 
embedded hydrogels. 
 
The Alg-PHEA hydrogels did form well within tissue environment upon the injection of precursor 
solution. The precursor solution did not move away from the injection site, and the hydrogel stayed 
89 
 
within the vicinity (Figure 5-13b). Incubating the tissue explants in neutral buffered solution, the 
hydrogels eventually all dissolved over time. However, the hydrogels having different mechanics 
dissolved at different rates. For example, the photographs and histological images taken 4 h after 
incubation showed that the hydrogel with the lowest rigidity, 10 % PHEA–PEGAm600 (DS4), indeed 
displayed the most dissolution (Figure 5-13c). The hydrogel with the highest rigidity, 20 % PHEA–
PEGAm200 (DS4), on the other hand, still maintained a significant extent of hydrogel structure. Taken 
together, this ex vivo result showed that Alg-PHEA hydrogels can be stably formed upon injection and 
undergo facile degradation within biological tissue environment, demonstrating the potential for 
implantable hydrogel delivery system. 
 
5.3.6 Dual Ionic Cross-Linked Alg-PHEA Hydrogels 
Alg-PHEA hydrogels have the ability to control mechanical and diffusional properties in a wide range, 
while maintaining facile dissolution. However, it is often desirable to create hydrogels with a greater 
range of structural durability and sustained presence. For this purpose, Alg-PHEA hydrogels were 
further cross-linked ionically using Ca2+ with varying concentrations (“Ca-Alg-PHEA”). Alginate has 
the ability to undergo ionic cross-linking with divalent cations such as Ca2+. [75, 160, 161] 
The elastic moduli of Ca-Alg-PHEA hydrogels measured after 1 h of incubation in aqueous buffered 
solution clearly showed the increase in moduli with Ca2+ concentration, (Figure 5-14a). The pore 
structures visualized with SEM imaging also demonstrated the gradual decrease in porosity with Ca2+ 
concentration (Figure 5-14b). These results effectively verified the additional and increasing degree of 
ionic cross-linking of Alg-PHEA hydrogels by the concentration of Ca2+. 
 
Figure 5-14. (a) Elastic moduli and (b) SEM cross-sectional images of Alg-PHEA hydrogels further 
cross-linked with various concentrations of Ca2+ up to 5 M (scale bar: 30 μm). 
Ca-Alg-PHEA hydrogels were incubated in neutral buffered solution, and their degradation over time 
was measured to assess the effect of secondary ionic cross-linking (Figure 5-15). Alg-PHEA hydrogel 
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made with 15% PHEA–PEGAm600 (DS4) without Ca2+ cross-linking was used as the control. The 
control condition led to complete dissolution after 5 h. However, Ca-Alg-PHEA hydrogels showed 
much greater resistance to dissolution (Figure 5-15b and c). More significantly, the degradation rate 
and subsequent complete dissolution time were shown to effectively depend on the degree of ionic 
cross-linking. 
 
Figure 5-15. (a) Photographs of Alg-PHEA (control) and Ca-Alg-PHEA hydrogel disks, with the initial 
diameter of 8 mm, taken at various times during incubation in aqueous buffered solution. The 
concentration of Ca2+ cross-linker was controlled up to 5 M. The diameter before complete dissolution 
are noted. (b, c) Time-resolved fractional change in elastic moduli (Et/E0) and degradation rates (kD), 
and (d, e) time-resolved fractional drug release profiles (Mt/M∞) and release kinetics (kR) of Alg-PHEA 
and Ca-Alg-PHEA hydrogels (*p < 0.05). 
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The drug release profiles using BSA as the model protein drug were also performed for the Ca-Alg-
PHEA hydrogels, and the release rates (kR) were obtained from Eq. 5-2 (Figure 5-15d and e). It is 
interesting to note that kR increased with Ca2+ concentration, from 1 to 5 M, despite having greater 
mechanical properties and structural durability. It is speculated that the excess local Ca2+ within 
hydrogels at higher concentrations being released dominantly at an earlier time frame (before 2 h) likely 
expedited the BSA release, since BSA is negatively charged at neutral buffered conditions having an 
isoelectric point of 5.3 and, thus, can electrostatically interact with Ca2+. [95] Taken together, in situ 
forming and mechanically tunable Alg-PHEA hydrogels that undergo facile dissolution could be further 
modulated via additional ionic cross-linking to delay and control the degradation and drug release rates. 
 
5.4 Conclusion 
In this study, an in situ forming and fast degrading hydrogel system was developed by inducing Schiff 
base formation between aldehyde-presenting alginate (Alg-ALD) and amine-presenting 
polyaspartamide. Since desired functional moieties can be conveniently grafted onto the 
polyaspartamide backbone via ring-opening addition reaction of amine-based nucleophiles with 
polysuccinimide, the graft architecture can be easily tuned by employing nucleophiles having linkers 
with varying lengths and densities. The polyaspartamide with amino poly(ethylene glycol) grafts, 
namely, poly(2-hydroxyethyl aspartamide)-g-amino-poly(ethylene glycol) (PHEA–PEGAm), could 
effectively control the mechanical properties of the resulting Alg-PHEA hydrogels in a broad range by 
the degree of amine substitution (DSAm) and the length of PEG linker, as well as the polymer 
concentration. Furthermore, the polyanionic nature of PHEA–PEGAm allowed expedited dissolution 
of hydrogels under physiological conditions, which was also significantly influenced by the graft 
architecture. The potential of Alg-PHEA hydrogels as a tissue injectable delivery systems was 
demonstrated ex vivo, in which hydrogel could be stably formed within the tissue upon injection, 
gradually degraded over time, and eventually completely dissolved. Moreover, the degradation rate and 
complete dissolution could be further modulated by additional ionic cross-linking of alginate. In sum, 
in situ forming, mechanically tunable, and facile degradable polyaspartamide-linked hydrogel via graft 
architecture presented in this study could be a highly versatile biomaterial platform for minimally 
invasive implantable delivery applications. 
 
Reprinted (adapted) with permission from (M. Kim, and C. Cha, Biomacromolecules 2020, 21(9), 3693–




CHAPTER 6. Summary and Future Perspective 
In this study, various properties of hydrogel are controlled at various levels while maintaining their 
intrinsic properties to meet the specific requirements. 
In chapter 2, While maintaining the intrinsic properties of PEG hydrogels, a mechanism for 
effectively controlling drug release kinetics was provided. By presenting pendant PEG chains with 
characteristic end functional groups in PEG hydrogels, their various physical properties (i.e., charge 
density and hydrophobicity) effectively controlled the release of proteins with different isoelectric 
points (pI) independent of the crosslinking density. 
In chapter 3, The mechanical properties and decomposition behavior of PEGDA-PEI hydrogels 
prepared by in situ crosslinking between PEGDA and PEI via Michael addition were investigated by 
varying the MW and concentration. This combination of tunable mechanical properties and 
degradation behavior of PEGDA-PEI hydrogels was highly effective in controlling the rate and mode 
of drug release by dual-mode drug release mechanisms. 
In chapter 4, in situ formation chitosan hydrogels via Schiff base formation controlled a wide range 
of mechanical properties without compromising gelation kinetics. Chitosan was conjugated with PEG 
grafts with controlled length and density (PEG-g-Cs), allowing water solubility at physiological pH, 
as well as directly affecting the mechanical results of the resulting Cs-PEG hydrogel. The adhesive 
properties and clinical potential of Cs-hydrogels was evaluated by ex vivo and in vivo model, which 
showed wound closure with minimal inflammation with similar mechanical properties as commercial 
tissue sealants. 
In chapter 5, By inducing the formation of Schiff bases between aldehyde-presented alginate (Alg-
ALD) and amine-presented polyasparmide, an in situ formation and rapid decomposition hydrogel 
system was developed. The potential of Alg-PHEA hydrogels as a tissue injectable delivery system 
was demonstrated ex vivo, in which hydrogel could be stably formed within the tissue upon injection, 
gradually degraded over time, and eventually completely dissolved. Moreover, their degradation rate 
and complete dissolution could be further modulated by additional ionic cross-linking of alginate. 
Through the development of in situ crosslinked hydrogels with controllable properties by varying 
the graft architecture and the modulation of the mechanical and physicochemical properties of 
hydrogels for refined drug release kinetics, the clinical application of hydrogels has been demonstrated 
in both in vitro and in vivo models. Therefore, by developing versatile hydrogels, it is expected to 
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